Analysis of marketing and entertainment effectiveness using central nervous system, autonomic nervous sytem, and effector data

Information

  • Patent Grant
  • 11250465
  • Patent Number
    11,250,465
  • Date Filed
    Thursday, April 30, 2020
    4 years ago
  • Date Issued
    Tuesday, February 15, 2022
    2 years ago
Abstract
An example system includes an analyzer to identify a degree of amplitude synchrony between a first pattern in a first frequency band in first neuro-response data and a second pattern in a second frequency band in the first neuro-response data, the first neuro-response data gathered via a first modality of collection from a subject while the subject is exposed to media, and modify the degree of amplitude synchrony in response to activity in second neuro-response data, the second neuro-response data gathered via a second modality of collection from the subject while the subject is exposed to the media, the activity corresponding in time to at least a portion of the first pattern or the second pattern. The example system includes an estimator to determine an effectiveness of the media based on the modified degree of amplitude synchrony.
Description
FIELD OF THE DISCLOSURE

The present disclosure relates to the analysis of the effectiveness of marketing and entertainment using central nervous system, autonomic nervous system, and effector measurement mechanisms.


BACKGROUND

Conventional systems for measuring the effectiveness of entertainment and marketing including advertising, brand messages, and product placement rely on either survey based evaluations or limited neurophysiological measurements used in isolation. These conventional systems provide some useful data but are highly inefficient and inaccurate due to a variety of semantic, syntactic, metaphorical, cultural, social, and interpretative errors and biases. The systems and techniques themselves used to obtain neurophysiological measurements are also highly limited.





BRIEF DESCRIPTION OF THE DRAWINGS

The disclosure may best be understood by reference to the following description taken in conjunction with the accompanying drawings, which illustrate particular examples.



FIG. 1 illustrates one example of a system for determining the effectiveness of marketing and entertainment by using central nervous system, autonomic nervous system, and effector measures.



FIG. 2 illustrates a particular example of a system having an intelligent protocol generator and presenter device and individual mechanisms for intra-modality response synthesis.



FIG. 3 illustrates a particular example of an intra-modality synthesis mechanism for Electroencephalography (EEG).



FIG. 4 illustrates another particular example of synthesis for Electroencephalography (EEG).



FIG. 5 illustrates a particular example of a cross-modality synthesis mechanism.



FIG. 6 is one example of a sample flow process diagram showing a technique for obtaining neurological and neurophysiological data.



FIG. 7 provides one example of a system that can be used to implement one or more mechanisms.





DETAILED DESCRIPTION

Reference will now be made in detail to some specific examples of the disclosure including the best modes contemplated by the inventors for carrying out the teachings of the disclosure. Examples of these specific examples are illustrated in the accompanying drawings. While the disclosure is described in conjunction with these specific examples, it will be understood that it is not intended to limit the disclosure to the described examples. On the contrary, it is intended to cover alternatives, modifications, and equivalents as may be included within the spirit and scope of the disclosure as defined by the appended claims.


For example, the techniques and mechanisms of the present disclosure will be described in the context of evaluating entertainment and marketing effectiveness. However, it should be noted that the techniques and mechanisms of the present disclosure apply to a variety of different types of entertainment and marketing such as video and audio streams, media advertising, product placement, brand effectiveness, printed advertisements, etc. It should be noted that various mechanisms and techniques can be applied to any type of stimuli. In the following description, numerous specific details are set forth in order to provide a thorough understanding of the present disclosure. Particular examples of the present disclosure may be implemented without some or all of these specific details. In other instances, well known process operations have not been described in detail in order not to unnecessarily obscure the present disclosure.


Various techniques and mechanisms of the present disclosure will sometimes be described in singular form for clarity. However, it should be noted that some examples include multiple iterations of a technique or multiple instantiations of a mechanism unless noted otherwise. For example, a system uses a processor in a variety of contexts. However, it will be appreciated that a system can use multiple processors while remaining within the scope of the present disclosure unless otherwise noted. Furthermore, the techniques and mechanisms of the present disclosure will sometimes describe a connection between two entities. It should be noted that a connection between two entities does not necessarily mean a direct, unimpeded connection, as a variety of other entities may reside between the two entities. For example, a processor may be connected to memory, but it will be appreciated that a variety of bridges and controllers may reside between the processor and memory. Consequently, a connection does not necessarily mean a direct, unimpeded connection unless otherwise noted.


Overview


Consequently, it is desirable to provide improved methods and apparatus for measuring and analyzing neurological and neurophysiological data, such as central nervous system, autonomic nervous system, and effector data obtained during evaluation of the effectiveness of entertainment and marketing materials.


Central nervous system, autonomic nervous system, and effector data is measured and analyzed to determine the effectiveness of marketing and entertainment stimuli. A data collection mechanism including multiple modalities such as Electroencephalography (EEG), Electrooculography (EOG), Galvanic Skin Response (GSR), etc., collects response data from subjects exposed to marketing and entertainment stimuli. A data cleanser mechanism filters the response data. The response data is enhanced using intra-modality response synthesis and/or a cross-modality response synthesis.


Examples

Conventional mechanisms for obtaining information about the effectiveness of various types of stimuli such as marketing and entertainment materials have generally relied on focus groups and surveys. Subjects are provided with oral and written mechanisms for conveying their thoughts and feelings elicited in response to a particular advertisement, brand, media clip, etc. These oral and written mechanisms provide some limited information on the effectiveness of the marketing and entertainment materials, but have a variety of limitations. For example, subjects may be unable or unwilling to express their true thoughts and feelings about a topic, or questions may be phrased with built in bias. Articulate subjects may be given more weight than nonexpressive ones. A variety of semantic, syntactic, metaphorical, cultural, social and interpretive biases and errors prevent accurate and repeatable evaluation.


Some efforts have been made to use isolated neurological and neurophysiological measurements to gauge subject responses. Some examples of central nervous system measurement mechanisms include Functional Magnetic Resonance Imaging (fMRI) and Electroencephalography (EEG). fMRI measures blood oxygenation in the brain that correlates with increased neural activity. However, current implementations of fMRI have poor temporal resolution of few seconds. EEG measures electrical activity associated with post synaptic currents occurring in the milliseconds range. Subcranial EEG can measure electrical activity with the most accuracy, as the bone and dermal layers weaken transmission of a wide range of frequencies. Nonetheless, surface EEG provides a wealth of electrophysiological information if analyzed properly.


Autonomic nervous system measurement mechanisms include Galvanic Skin Response (GSR), Electrocardiograms (EKG), pupillary dilation, etc. Effector measurement mechanisms include Electrooculography (EOG), eye tracking, facial emotion encoding, reaction time, etc.


Some conventional mechanisms cite a particular neurological or neurophysiological measurement characteristic as indicating a particular thought, feeling, mental state, or ability. For example, one mechanism purports that the contraction of a particular facial muscle indicates the presence of a particular emotion. Others measure general activity in particular areas of the brain and suggest that activity in one portion may suggest lying while activity in another portion may suggest truthfulness. However, these mechanisms are severely limited in their ability to accurately reflect a subject's actual thoughts. It is recognized that a particular region of the brain can not be mapped to a particular thought. Similarly, a particular eye movement can not be mapped to a particular emotion. Even when there is a strong correlation between a particular measured characteristic and a thought, feeling, or mental state, the correlations are not perfect, leading to a large number of false positives and false negatives.


Consequently, the techniques and mechanisms of the present disclosure intelligently blend multiple modes and manifestations of precognitive neural signatures with cognitive neural signatures and post cognitive neurophysiological manifestations to more accurately access the effectiveness of marketing and entertainment materials. In some examples, autonomic nervous system measures are themselves used to validate central nervous system measures. Effector and behavior responses are blended and combined with other measures.


Intra-modality measurement enhancements are made in addition to the cross-modality measurement mechanism enhancements. According to various examples, brain activity is measured not just to determine the regions of activity, but to determine interactions and types of interactions between various regions. The techniques and mechanisms of the present disclosure recognize that interactions between neural regions support orchestrated and organized behavior. Thoughts and abilities are not merely based on one part of the brain but instead rely on network interactions between brain regions.


The techniques and mechanisms of the present disclosure further recognize that different frequency bands used for multi-regional communication can be indicative of the effectiveness of stimuli. For example, associating a name to a particular face may entail activity in communication pathways tuned to particular frequencies. According to various examples, select frequency bands are analyzed after filtering. The techniques and mechanisms of the present disclosure also recognize that high gamma band frequencies have significance. Inter-frequency coupling in the signals have also been determined to indicate effectiveness. Signals modulated on a carrier wave have also been determined to be important in evaluating thoughts and actions. In particular examples, the types of frequencies measured are subject and/or task specific. For example, particular types of frequencies in specific pathways are measured if a subject is being exposed to a new product.


In particular examples, evaluations are calibrated to each subject and synchronized across subjects. In particular examples, templates are created for subjects to create a baseline for measuring pre and post stimulus differentials. According to various examples, stimulus generators are intelligent, and adaptively modify specific parameters such as exposure length and duration for each subject being analyzed.


Consequently, the techniques and mechanisms of the present disclosure provide a central nervous system, autonomic nervous system, and effector measurement and analysis system that can be applied to evaluate the effectiveness of materials such as marketing and entertainment materials. Marketing materials may include advertisements, commercials, media clips, brand messages, product brochures, company logos, etc. An intelligent stimulus generation mechanism intelligently adapts output for particular users and purposes. A variety of modalities can be used including EEG, GSR, EKG, pupillary dilation, EOG, eye tracking, facial emotion encoding, reaction time, etc. Individual modalities such as EEG are enhanced by intelligently recognizing neural region communication pathways. Cross modality analysis is enhanced using a synthesis and analytical blending of central nervous system, autonomic nervous system, and effector signatures. Synthesis and analysis by mechanisms such as time and phase shifting, correlating, and validating intra-modal determinations allow generation of a composite output characterizing the effectiveness of various stimuli.



FIG. 1 illustrates one example of a system for determining the effectiveness of marketing and entertainment by using central nervous system, autonomic nervous system, and effector measures. According to various examples, the neuroanalysis system includes a protocol generator and presenter device 101. In particular examples, the protocol generator and presenter device 101 is merely a presenter device and merely presents stimuli to a user. The stimuli may be a media clip, a commercial, a brand image, a magazine advertisement, a movie, an audio presentation, particular tastes, smells, textures and/or sounds. The stimuli can involve a variety of senses and occur with or without human supervision. Continuous and discrete modes are supported. According to various examples, the protocol generator and presenter device 101 also has protocol generation capability to allow intelligent customization of stimuli provided to a subject.


According to various examples, the subjects are connected to data collection devices 105. The data collection devices 105 may include a variety of neurological and neurophysiological measurement mechanisms such as EEG, EOG, GSR, EKG, pupillary dilation, eye tracking, facial emotion encoding, and reaction time devices, etc. In particular examples, the data collection devices 105 include EEG 111, EOG 113, and GSR 115. In some instances, only a single data collection device is used. Data collection may proceed with or without human supervision.


The data collection device 105 collects neuro-physiological data from multiple sources. This includes a combination of devices such as central nervous system sources (EEG), autonomic nervous system sources (GSR, EKG, pupillary dilation), and effector sources (EOG, eye tracking, facial emotion encoding, reaction time). In particular examples, data collected is digitally sampled and stored for later analysis. In particular examples, the data collected could be analyzed in real-time. According to particular examples, the digital sampling rates are adaptively chosen based on the neurophysiological and neurological data being measured.


In one particular example, the neurological and neurophysiological analysis system includes EEG 111 measurements made using scalp level electrodes, EOG 113 measurements made using shielded electrodes to track eye data, GSR 115 measurements performed using a differential measurement system, a facial muscular measurement through shielded electrodes placed at specific locations on the face, and a facial affect graphic and video analyzer adaptively derived for each individual.


In particular examples, the data collection devices are clock synchronized with a protocol generator and presenter device 101. The data collection system 105 can collect data from a single individual (1 system), or can be modified to collect synchronized data from multiple individuals (N+1 system). The N+1 system may include multiple individuals synchronously tested in isolation or in a group setting. In particular examples, the data collection devices also include a condition evaluation subsystem that provides auto triggers, alerts and status monitoring and visualization components that continuously monitor the status of the subject, data being collected, and the data collection instruments. The condition evaluation subsystem may also present visual alerts and automatically trigger remedial actions.


According to various examples, the neurological and neurophysiological analysis system also includes a data cleanser device 121. In particular examples, the data cleanser device 121 filters the collected data to remove noise, artifacts, and other irrelevant data using fixed and adaptive filtering, weighted averaging, advanced component extraction (like PCA, ICA), vector and component separation methods, etc. This device cleanses the data by removing both exogenous noise (where the source is outside the physiology of the subject) and endogenous artifacts (where the source could be neurophysiological like muscle movement, eye blinks, etc.).


The artifact removal subsystem includes mechanisms to selectively isolate and review the response data and identify epochs with time domain and/or frequency domain attributes that correspond to artifacts such as line frequency, eye blinks, and muscle movements. The artifact removal subsystem then cleanses the artifacts by either omitting these epochs, or by replacing these epoch data with an estimate based on the other clean data (for example, an EEG nearest neighbor weighted averaging approach).


According to various examples, the data cleanser device 121 is implemented using hardware, firmware, and/or software. It should be noted that although a data cleanser device 121 is shown located after a data collection device 105 and before synthesis devices 131 and 141, the data cleanser device 121 like other components may have a location and functionality that varies based on system implementation. For example, some systems may not use any automated data cleanser device whatsoever. In other systems, data cleanser devices may be integrated into individual data collection devices.


The data cleanser device 121 passes data to the intra-modality response synthesizer 131. The intra-modality response synthesizer 131 is configured to customize and extract the independent neurological and neurophysiological parameters for each individual in each modality and blend the estimates within a modality analytically to elicit an enhanced response to the presented stimuli. In particular examples, the intra-modality response synthesizer also aggregates data from different subjects in a dataset.


According to various examples, the cross-modality response synthesis or fusion device 141 blends different intra-modality responses, including raw signals and signals output from synthesizer 131. The combination of signals enhances the measures of effectiveness within a modality. The cross-modality response fusion device 141 can also aggregate data from different subjects in a dataset.


According to various examples, the system also includes a composite enhanced effectiveness estimator (CEEE) that combines the enhanced responses and estimates from each modality to provide a blended estimate of the effectiveness of the marketing and entertainment stimuli for various purposes. Stimulus effectiveness measures are output at 161.



FIG. 2 illustrates a particular example of a system having an intelligent protocol generator and presenter device (where the intelligence could include a feedback based on prior responses) and individual mechanisms for intra-modality response synthesis.


According to various examples, the system includes a protocol generator and presenter device 201. In particular examples, the protocol generator and presenter device 201 is merely a presenter device and merely presents preconfigured stimuli to a user. The stimuli may be media clips, commercials, brand images, magazine advertisements, movies, audio presentations, particular tastes, textures, smells, and/or sounds. The stimuli can involve a variety of senses and occur with or without human supervision. Continuous and discrete modes are supported. According to various examples, the protocol generator and presenter device 201 also has protocol generation capability to allow intelligent modification of the types of stimuli provided to a subject. In particular examples, the protocol generator and presenter device 201 receives information about stimulus effectiveness measures from component 261.


The protocol generator and presenter device 201 dynamical adapts stimuli presentation by using information from the analysis of attention, analysis of emotional engagement, analysis of memory retention, analysis of overall visual, audio, other sensory effectiveness, and ad, show, or content effectiveness, implicit analysis of brand impact, implicit analysis of brand meaning, implicit analysis of brand archetype, implicit analysis of brand imagery, implicit analysis of brand words, explicit analysis of brand impact, explicit analysis of brand meaning, explicit analysis of brand archetype, explicit analysis of brand imagery, explicit analysis of brand words; analysis of characters in the ad, analysis of emotive response to characters in the ad/show/content, analysis of character interaction in the ad/show/content; elicitation of core components of the ad/show/content for print purposes, elicitation of core components of the ad/show/content for billboard purposes; elicitation of the ocular metrics like hot-zones in the ad/show/content by eye dwell time, micro and macro saccade separation, saccadic returns to points of interest; elicitation of points for product placement, elicitation of points for logo and brand placement; analysis of game effectiveness, analysis of product placement in games; analysis of website effectiveness, webpage dropoff in a site. According to various examples, the information is provided by component 261. In particular examples, the protocol generator and presenter device 201 can itself obtain some of this information


The protocol generator and presenter device 201 uses a data model along with linguistic and image tools like valence, arousal, meaning matched word/phrase generators, valence and arousal matched image/video selectors to generate parameters regarding the experiment. In particular examples, the protocol generator and presenter device 201 may vary individual presentation parameters like time and duration of the experiment, the number of repetitions of the stimuli based on signal to noise requirements, and the number and repetitions of the stimuli for habituation and wear-out studies, the type and number of neuro-physiological baselines, and the self reporting surveys to include.


In particular examples, the protocol generator and presenter device 201 customizes presentations to a group of subjects or to individual subjects. According to various examples, the subjects are connected to data collection devices 205. The data collection devices 205 may involve any type of neurological and neurophysiological mechanism such as EEG, EOG, GSR, EKG, pupillary dilation, eye tracking, facial emotion encoding, reaction rime, etc. In particular examples, the data collection devices 205 include EEG 211, EOG 213, and GSR 215. In some instances, only a single modality is used. In other instances, multiple modalities are used and may vary depending on the type of effectiveness evaluation. Data collection may proceed without or without human supervision.


The data collection device 205 automatically collects neuro-physiological data from multiple sources. This includes a combination of devices such as central nervous system sources (EEG), autonomic nervous system sources (GSR, EKG, pupillary dilation), and effector sources (EOG, eye tracking, facial emotion encoding, reaction time). In particular examples, data collected is digitally sampled and stored for later analysis. The digital sampling rates are adaptively chosen based on the type of neurophysiological and neurological data being measured.


In particular examples, the system includes EEG 211 measurements made using scalp level electrodes, EOG 213 measurements made using shielded electrodes to track eye data, GSR 215 measurements performed using a differential measurement system, and a facial affect graphic and video analyzer adaptively derived for each individual.


According to various examples, the data collection devices are clock synchronized with a protocol generator and presenter device 201. The data collection system 205 can collect data from a single individual (1 system), or can be modified to collect synchronized data from multiple individuals (N+1 system). The N+1 system could include multiple individuals synchronously recorded in a group setting or in isolation. In particular examples, the data collection devices also include a condition evaluation subsystem that provides auto triggers, alerts and status monitoring and visualization components that continuously monitor the status of the data being collected as well as the status of the data collection instruments themselves. The condition evaluation subsystem may also present visual alerts and automatically trigger remedial actions.


According to various examples, the system also includes a data cleanser device 221. In particular examples, the data cleanser device 221 filters the collected data to remove noise, artifacts, and other irrelevant data using fixed and adaptive filtering, weighted averaging, advanced component extraction (like PCA, ICA), vector and component separation methods, etc. This device cleanses the data by removing both exogenous noise (where the source is outside the physiology of the subject) and endogenous artifacts (where the source could be neurophysiological like muscle movement, eye blinks).


The artifact removal subsystem includes mechanisms to selectively isolate and review the output of each of the data and identify epochs with time domain and/or frequency domain attributes that correspond to artifacts such as line frequency, eye blinks, and muscle movements. The artifact removal subsystem then cleanses the artifacts by either omitting these epochs, or by replacing these epoch data with an estimate based on the other clean data (for example, an EEG nearest neighbor weighted averaging approach), or removes these components from the signal.


According to various examples, the data cleanser device 221 is implemented using hardware, firmware, and/or software. It should be noted that although a data cleanser device 221 is shown located after a data collection device 205 and before synthesis devices 231 and 241, the data cleanser device 221 like other components may have a location and functionality that varies based on system implementation. For example, some systems may not use any automated data cleanser device whatsoever. In other systems, data cleanser devices may be integrated into individual data collection devices.


The data cleanser device 221 passes data to the intra-modality response synthesizer 231. The intra-modality response synthesizer is configured to customize and extract the independent neurological and neurophysiological parameters for each individual in each modality and blend the estimates within a modality analytically to elicit an enhanced response to the presented stimuli. In particular examples, the intra-modality response synthesizer also aggregates data from different subjects in a dataset. According to various examples, various modules perform synthesis in parallel or in series, and can operate on data directly output from a data cleanser device 221 or operate on data output from other modules. For example, EEG synthesis module 233 can operate on the output of EOG synthesis module 235. GSR module 237 can operate on data output from EEG module 233.


According to various examples, the cross-modality response synthesis or fusion device 241 blends different intra-modality responses, including raw signals as well as signals output from synthesizer 231. The combination of signals enhances the measures of effectiveness within a modality. The cross-modality response fusion device 241 can also aggregate data from different subjects in a dataset.


According to various examples, the neuro analysis system also includes a composite enhanced effectiveness estimator (CEEE) that combines the enhanced responses and estimates from each modality to provide a blended estimate of the effectiveness of the marketing and advertising stimuli for various purposes. Stimulus effectiveness measures are output at 261. A portion or all of the effectiveness measures (intra-modality synthesizer, cross modality fusion device, and/or the CEEE) can be provided as feedback to a protocol generator and presenter device 201 to further customize stimuli presented to users 203.



FIG. 3 illustrates a particular example of an intra-modality synthesis mechanism. In particular examples, EEG response data is synthesized to provide an enhanced assessment of marketing and entertainment effectiveness. According to various examples, EEG measures electrical activity resulting from thousands of simultaneous neural processes associated with different portions of the brain. EEG data can be classified in various bands. According to various examples, brainwave frequencies includes delta, theta, alpha, beta, and gamma frequency ranges. Delta waves are classified as those less than 4 Hz and are prominent during deep sleep. Theta waves have frequencies between 3.5 to 7.5 Hz and are associated with memories, attention, emotions, and sensations. Theta waves are typically prominent during states of internal focus.


Alpha frequencies reside between 7.5 and 13 Hz and typically peak around 10 Hz. Alpha waves are prominent during states of relaxation. Beta waves have a frequency range between 14 and 30 Hz. Beta waves are prominent during states of motor control, long range synchronization between brain areas, analytical problem solving, judgment, and decision making. Gamma waves occur between 30 and 60 Hz and are involved in binding of different populations of neurons together into a network for the purpose of carrying out a certain cognitive or motor function, as well as in attention and memory. Because the skull and dermal layers attenuate waves in this frequency range, brain waves above 75-80 Hz are difficult to detect and are often not used for stimuli response assessment.


However, the techniques and mechanisms of the present disclosure recognize that analyzing high gamma band (kappa-band: Above 60 Hz) measurements, in addition to theta, alpha, beta, and low gamma band measurements, enhances neurological attention, emotional engagement and retention component estimates. In particular examples, EEG measurements including difficult to detect high gamma or kappa band measurements are obtained, enhanced, and evaluated at 301. At 303, subject and task specific signature sub-bands in the theta, alpha, beta, gamma and kappa bands are identified to provide enhanced response estimates. According to various examples, high gamma waves (kappa-band) above 80 Hz (typically detectable with sub-cranial EEG and magnetoencephalography) can be used in inverse model-based enhancement of the frequency responses to the stimuli.


Various examples of the present disclosure recognize that particular sub-bands within each frequency range have particular prominence during certain activities. A subset of the frequencies in a particular band is referred to herein as a sub-band. For example, a sub-band may include the 40-45 Hz range within the gamma band. In particular examples, multiple sub-bands within the different bands are selected while remaining frequencies are band pass filtered. In particular examples, multiple sub-band responses may be enhanced, while the remaining frequency responses may be attenuated.


At 305, inter-regional coherencies of the sub-band measurements are determined. According to various examples, inter-regional coherencies are determined using gain and phase coherences, Bayesian references, mutual information theoretic measures of independence and directionality, and Granger causality techniques of the EEG response in the different bands. In particular examples, inter-regional coherencies are determined using fuzzy logic to estimate effectiveness of the stimulus in evoking specific type of responses in individual subjects.


At 307, inter-hemispheric time-frequency measurements are evaluated. In particular examples, asymmetries in specific band powers, asymmetries in inter-regional intra-hemispheric coherences, and asymmetries in inter-regional intra-hemisphere inter-frequency coupling are analyzed to provide measures of emotional engagement.


At 309, inter-frequency coupling assessments of the response are determined. In particular examples, a coupling index corresponding to the measure of specific band activity in synchrony with the phase of other band activity is determined to ascertain the significance of the marketing and advertising stimulus or sub-sections thereof. At 313, a reference scalp power frequency curve is determined using a baseline electrocorticogram (ECoG) power by frequency function driven model. The reference scale power frequency curve is compared to an individual scalp record power by frequency curve to derive scaled estimates of marketing and entertainment effectiveness. According to various examples, scaled estimates are derived used fuzzy scaling.


At 315, an information theory based band-weighting model is used for adaptive extraction of selective dataset specific, subject specific, task specific bands to enhance the effectiveness measure. Adaptive extraction may be performed using fuzzy scaling. At 321, stimuli can be presented and enhanced measurements determined multiple times to determine the variation or habituation profiles across multiple presentations. Determining the variation and/or habituation profiles provides an enhanced assessment of the primary responses as well as the longevity (wear-out) of the marketing and entertainment stimuli. At 323, the synchronous response of multiple individuals to stimuli presented in concert is measured to determine an enhanced across subject synchrony measure of effectiveness. According to various examples, the synchronous response may be determined for multiple subjects residing in separate locations or for multiple subjects residing in the same location.


Although a variety of synthesis mechanisms are described, it should be recognized that any number of mechanisms can be applied in sequence or in parallel with or without interaction between the mechanisms. In some examples, processes 321 and 323 can be applied to any modality. FIG. 4 illustrates a particular example of synthesis for Electroencephalography (EEG) data, including ERP and continuous EEG.


ERPs can be reliably measured using electroencephalography (EEG), a procedure that measures electrical activity of the brain. Although an EEG reflects thousands of simultaneously ongoing brain processes, the brain response to a certain stimulus may not be visible using EEG. ERP data includes cognitive neurophysiological responses that manifests after the stimulus is presented. In many instances, it is difficult to see an ERP after the presentation of a single stimulus. The most robust ERPs are seen after tens or hundreds of individual presentations are combined. This combination removes noise in the data and allows the voltage response to the stimulus to stand out more clearly. In addition to averaging the example includes techniques to extract single trial evoked information from the ongoing EEG.


While evoked potentials reflect the processing of the physical stimulus, event-related potentials are caused by the “higher” processes, that might involve memory, expectation, attention, or changes in the mental state, among others. According to various examples, evidence of the occurrence or non-occurrence of specific time domain components in specific regions of the brain are used to measure subject responsiveness to specific stimulus.


According to various examples, ERP data can be enhanced using a variety of mechanisms. At 401, event related time-frequency analysis of stimulus response—event related power spectral perturbations (ERPSPs)—is performed across multiple frequency bands such as theta, delta, alpha, beta, gamma and high gamma (kappa). According to various examples, a baseline ERP is determined. At 403, a differential event related potential (DERP) is evaluated to assess stimulus attributable differential responses.


At 405, a variety of analysis techniques including principal component analysis (PCA), independent component analysis (ICA), and Monte Carlos analysis can be applied to evaluate an ordered ranking of the effectiveness across multiple stimuli. In particular examples, PCA is used to reduce multidimensional data sets to lower dimensions for analysis. ICA is typically used to separate multiple components in a signal. Monte Carlo relies on repeated random sampling to compute results. According to various examples, an ERP scenario is developed at 407 to determine a subject, session and task specific response baseline. The baseline can then be used to enhance the sensitivity of other ERP responses to the tested stimuli.


At 421, stimuli can be presented and enhanced measurements determined multiple times to determine the variation or habituation profiles across multiple presentations. Determining the variation and/or habituation profiles provides an enhanced assessment of the primary responses as well as the longevity (wear-out) of the marketing and entertainment stimuli. At 423, the synchronous response of multiple individuals to stimuli presented in concert is measured to determine an enhanced across subject synchrony measure of effectiveness. According to various examples, the synchronous response may be determined for multiple subjects residing in separate locations or for multiple subjects residing in the same location.


A variety of processes such as processes 421, and 423 can be applied to a number of modalities, including EOG, eye tracking, GSR, facial emotion encoding, etc. In addition, synthesis of data from mechanisms such as EOG and eye tracking can also benefit from the grouping objects of interest into temporally and spatially defined entities using micro and macro saccade patterns. Gaze, dwell, return of eye movements to primarily center around the defined entities of interest and inhibition of return to novel regions of the material being evaluated are measured to determine the degree of engagement and attention evoked by the stimulus.


Although intra-modality synthesis mechanisms provide enhanced effectiveness data, additional cross-modality synthesis mechanisms can also be applied. FIG. 5 illustrates a particular example of a cross-modality synthesis mechanism. A variety of mechanisms such as EEG 501, Eye Tracking 503, GSR 505, EOG 507, and facial emotion encoding 509 are connected to a cross-modality synthesis mechanism. Other mechanisms as well as variations and enhancements on existing mechanisms may also be included. According to various examples, data from a specific modality can be enhanced using data from one or more other modalities. In particular examples, EEG typically makes frequency measurements in different bands like alpha, beta and gamma to provide estimates of effectiveness. However, the techniques of the present disclosure recognize that effectiveness measures can be enhanced further using information from other modalities.


For example, facial emotion encoding measures can be used to enhance the valence of the EEG emotional engagement measure. EOG and eye tracking saccadic measures of object entities can be used to enhance the EEG estimates of effectiveness including but not limited to attention, emotional engagement, and memory retention. According to various examples, a cross-modality synthesis mechanism performs time and phase shifting of data to allow data from different modalities to align. In some examples, it is recognized that an EEG response will often occur hundreds of milliseconds before a facial emotion measurement changes. Correlations can be drawn and time and phase shifts made on an individual as well as a group basis. In other examples, saccadic eye movements may be determined as occurring before and after particular EEG responses. According to various examples, time corrected GSR measures are used to scale and enhance the EEG estimates of effectiveness including attention, emotional engagement and memory retention measures.


Evidence of the occurrence or non-occurrence of specific time domain difference event-related potential components (like the DERP) in specific regions correlates with subject responsiveness to specific stimulus. According to various examples, ERP measures are enhanced using EEG time-frequency measures (ERPSP) in response to the presentation of the marketing and entertainment stimuli. Specific portions are extracted and isolated to identify ERP, DERP and ERPSP analyses to perform. In particular examples, an EEG frequency estimation of attention, emotion and memory retention (ERPSP) is used as a co-factor in enhancing the ERP, DERP and time-domain response analysis.


EOG measures saccades to determine the presence of attention to specific objects of stimulus. Eye tracking measures the subject's gaze path, location and dwell on specific objects of stimulus. According to various examples, EOG and eye tracking is enhanced by measuring the presence of lambda waves (a neurophysiological index of saccade effectiveness) in the ongoing EEG in the occipital and extra striate regions, triggered by the slope of saccade-onset to estimate the effectiveness of the EOG and eye tracking measures. In particular examples, specific EEG signatures of activity such as slow potential shifts and measures of coherence in time-frequency responses at the Frontal Eye Field (FEF) regions that preceded saccade-onset are measured to enhance the effectiveness of the saccadic activity data.


GSR typically measures the change in general arousal in response to stimulus presented. According to various examples, GSR is enhanced by correlating EEG/ERP responses and the GSR measurement to get an enhanced estimate of subject engagement. The GSR latency baselines are used in constructing a time-corrected GSR response to the stimulus. The time-corrected GSR response is co-factored with the EEG measures to enhance GSR effectiveness measures.


According to various examples, facial emotion encoding uses templates generated by measuring facial muscle positions and movements of individuals expressing various emotions prior to the testing session. These individual specific facial emotion encoding templates are matched with the individual responses to identify subject emotional response. In particular examples, these facial emotion encoding measurements are enhanced by evaluating inter-hemispherical asymmetries in EEG responses in specific frequency bands and measuring frequency band interactions. The techniques of the present disclosure recognize that not only are particular frequency bands significant in EEG responses, but particular frequency bands used for communication between particular areas of the brain are significant. Consequently, these EEG responses enhance the EMG, graphic and video based facial emotion identification.



FIG. 6 is a flow process diagram showing a technique for obtaining neurological and neurophysiological data. At 601, a protocol is generated and stimulus is provided to one or more subjects. According to various examples, stimulus includes streaming video, media clips, printed materials, individual products, etc. The protocol determines the parameters surrounding the presentation of stimulus, such as the number of times shown, the duration of the exposure, sequence of exposure, segments of the stimulus to be shown, etc. Subjects may be isolated during exposure or may be presented materials in a group environment with or without supervision. At 603, subject responses are collected using a variety of modalities, such as EEG, ERP, EOG, GSR, etc. In some examples, verbal and written responses can also be collected and correlated with neurological and neurophysiological responses. At 605, data is passed through a data cleanser to remove noise and artifacts that may make data more difficult to interpret. According to various examples, the data cleanser removes EEG electrical activity associated with blinking and other endogenous/exogenous artifacts.


At 611, intra-modality response synthesis is performed to enhance effectiveness measures. At 613, cross-modality response synthesis is performed to further enhance effectiveness measures. It should be noted that in some particular instances, one type of synthesis may be performed without performing the other type of synthesis. For example, cross-modality response synthesis may be performed with or without intra-modality synthesis. At 615, a composite enhanced effectiveness estimate is provided. At 621, feedback is provided to the protocol generator and presenter device for additional evaluations. This feedback could be provided by the cross-modality response synthesizer or other mechanisms.


According to various examples, various mechanisms such as the data collection mechanisms, the intra-modality synthesis mechanisms, cross-modality synthesis mechanisms, etc. are implemented on multiple devices. However, it is also possible that the various mechanisms be implemented in hardware, firmware, and/or software in a single system. FIG. 7 provides one example of a system that can be used to implement one or more mechanisms. For example, the system shown in FIG. 7 may be used to implement a data cleanser device or a cross-modality responses synthesis device.


According to particular examples, a system 700 suitable for implementing particular examples of the present disclosure includes a processor 701, a memory 703, an interface 711, and a bus 715 (e.g., a PCI bus). When acting under the control of appropriate software or firmware, the processor 701 is responsible for such tasks such as pattern generation. Various specially configured devices can also be used in place of a processor 701 or in addition to processor 701. The complete implementation can also be done in custom hardware. The interface 711 is typically configured to send and receive data packets or data segments over a network. Particular examples of interfaces the device supports include host bus adapter (HBA) interfaces, Ethernet interfaces, frame relay interfaces, cable interfaces, DSL interfaces, token ring interfaces, and the like.


In addition, various very high-speed interfaces may be provided such as fast Ethernet interfaces, Gigabit Ethernet interfaces, ATM interfaces, HSSI interfaces, POS interfaces, FDDI interfaces and the like. Generally, these interfaces may include ports appropriate for communication with the appropriate media. In some cases, they may also include an independent processor and, in some instances, volatile RAM. The independent processors may control such communications intensive tasks as data synthesis.


According to particular examples, the system 700 uses memory 703 to store data, algorithms and program instructions. The program instructions may control the operation of an operating system and/or one or more applications, for example. The memory or memories may also be configured to store received data and process received data.


Because such information and program instructions may be employed to implement the systems/methods described herein, the present disclosure relates to tangible, machine readable media that include program instructions, state information, etc. for performing various operations described herein. Examples of machine-readable media include, but are not limited to, magnetic media such as hard disks, floppy disks, and magnetic tape; optical media such as CD-ROM disks and DVDs; magneto-optical media such as optical disks; and hardware devices that are specially configured to store and perform program instructions, such as read-only memory devices (ROM) and random access memory (RAM). Examples of program instructions include both machine code, such as produced by a compiler, and files containing higher level code that may be executed by the computer using an interpreter.


Although the foregoing disclosure has been described in some detail for purposes of clarity of understanding, it will be apparent that certain changes and modifications may be practiced within the scope of the appended claims. Therefore, the present examples are to be considered as illustrative and not restrictive and the disclosure is not to be limited to the details given herein, but may be modified within the scope and equivalents of the appended claims.

Claims
  • 1. A system for transforming neuro-response data collected using a first modality of collection and a second modality of collection into a measure of effectiveness of media, the system comprising: an analyzer to: identify a degree of amplitude synchrony between a first pattern in a first frequency band in first neuro-response data and a second pattern in a second frequency band in the first neuro-response data, the first neuro-response data gathered via the first modality of collection from a subject while the subject is exposed to the media; andmodify the degree of amplitude synchrony in response to activity in second neuro-response data, the second neuro-response data gathered via the second modality of collection from the subject while the subject is exposed to the media, the activity corresponding in time to at least a portion of the first pattern or the second pattern; andan estimator to determine an effectiveness of the media based on the modified degree of amplitude synchrony.
  • 2. The system of claim 1, wherein the analyzer is to identify the degree of amplitude synchrony based on a first amplitude in the first pattern relative to a second amplitude in the second pattern.
  • 3. The system of claim 1, wherein the analyzer is to: determine a first change between a first amplitude in the first frequency band and a second amplitude in the second frequency band;determine a second change between a third amplitude in the second frequency band a fourth amplitude in the second frequency band; andidentify the degree of amplitude synchrony based on a coherence between the first change and the second change.
  • 4. The system of claim 1, wherein the analyzer is to further determine a degree of phase synchrony between the first pattern in the first frequency band and the second pattern in the second frequency band and the estimator to is to further determine the effectiveness of the media based on the degree of phase synchrony.
  • 5. The system of claim 1, wherein the first frequency band has a first frequency range and the second frequency band has a second frequency range, the second frequency range different than the first frequency range.
  • 6. The system of claim 1, wherein the first frequency band and the second frequency band include the same frequency range, the first frequency band gathered from a first hemisphere of a brain of the subject and the second frequency band gathered from a second hemisphere of the brain.
  • 7. The system of claim 1, wherein the first modality of collection includes electroencephalography and the second modality of collection includes galvanic skin response.
  • 8. A tangible machine readable storage device or storage disc comprising instructions that, when executed, cause a machine to at least: identify a degree of amplitude synchrony between a first pattern in a first frequency band in first neuro-response data and a second pattern in a second frequency band in the first neuro-response data, the first neuro-response data gathered via a first modality of collection from a subject while the subject is exposed to media;modify the degree of amplitude synchrony in response to activity in second neuro-response data, the second neuro-response data gathered via a second modality of collection from the subject while the subject is exposed to the media, the activity corresponding in time to at least a portion of the first pattern or the second pattern; anddetermine an effectiveness of the media based on the modified degree of amplitude synchrony.
  • 9. The tangible machine readable storage device or storage disk of claim 8, wherein the instructions, when executed, cause the machine to identify the degree of amplitude synchrony based on a first amplitude in the first pattern relative to a second amplitude in the second pattern.
  • 10. The tangible machine readable storage device or storage disk of claim 8, wherein the instructions, when executed, cause the machine to: determine a first change between a first amplitude in the first frequency band and a second amplitude in the second frequency band;determine a second change between a third amplitude in the second frequency band a fourth amplitude in the second frequency band; andidentify the degree of amplitude synchrony based on a coherence between the first change and the second change.
  • 11. The tangible machine readable storage device or storage disk of claim 8, wherein the instructions cause the machine to: determine a degree of phase synchrony between the first pattern in the first frequency band and the second pattern in the second frequency band; anddetermine the effectiveness of the media based the degree of phase synchrony.
  • 12. The tangible machine readable storage device or storage disk of claim 8, wherein the first frequency band has a first frequency range and the second frequency band has a second frequency range, the second frequency range different than the first frequency range.
  • 13. The tangible machine readable storage device or storage disk of claim 8, wherein the first frequency band and the second frequency band include the same frequency range, the first frequency band gathered from a first hemisphere of a brain of the subject and the second frequency band gathered from a second hemisphere of the brain.
  • 14. An apparatus comprising: memory including machine readable instructions; andprocessor circuitry to execute the instructions to: identify a degree of amplitude synchrony between a first pattern in a first frequency band in first neuro-response data and a second pattern in a second frequency band in the first neuro-response data, the first neuro-response data gathered via a first modality of collection from a subject while the subject is exposed to media;modify the degree of amplitude synchrony in response to activity in second neuro-response data, the second neuro-response data gathered via a second modality of collection from the subject while the subject is exposed to the media, the activity corresponding in time to at least a portion of the first pattern or the second pattern; anddetermine an effectiveness of the media based on the modified degree of amplitude synchrony.
  • 15. The apparatus of claim 14, wherein the processor circuitry is to execute the instructions to identify the degree of amplitude synchrony based on a first amplitude in the first pattern relative to a second amplitude in the second pattern.
  • 16. The apparatus of claim 14, wherein the processor circuitry is to execute the instructions to: determine a first change between a first amplitude in the first frequency band and a second amplitude in the second frequency band;determine a second change between a third amplitude in the second frequency band a fourth amplitude in the second frequency band; andidentify the degree of amplitude synchrony based on a coherence between the first change and the second change.
  • 17. The apparatus of claim 14, wherein the processor circuitry is to execute the instructions to: determine a degree of phase synchrony between the first pattern in the first frequency band and the second pattern in the second frequency band; anddetermine the effectiveness of the media based the degree of phase synchrony.
  • 18. The apparatus of claim 14, wherein the first frequency band has a first frequency range and the second frequency band has a second frequency range, the second frequency range different than the first frequency range.
  • 19. The apparatus of claim 14, wherein the first frequency band and the second frequency band include the same frequency range, the first frequency band gathered from a first hemisphere of a brain of the subject and the second frequency band gathered from a second hemisphere of the brain.
  • 20. The apparatus of claim 14, wherein the first modality of collection includes electroencephalography and the second modality of collection includes galvanic skin response.
CROSS-REFERENCE TO RELATED APPLICATIONS

This patent arises from a continuation of U.S. patent application Ser. No. 15/967,939 now U.S. Pat. No. 10,679,241), which was filed on May 1, 2018, which arises from a continuation of U.S. patent application Ser. No. 13/730,511, which was filed on Dec. 28, 2012, which arises from a continuation of U.S. patent application Ser. No. 12/056,190 (now U.S. Pat. No. 8,484,081), which was filed on Mar. 26, 2008, and claims the benefit under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 60/908,742, which was filed on Mar. 29, 2007. U.S. patent application Ser. No. 15/967,939, U.S. patent application Ser. No. 13/730,511, U.S. patent application Ser. No. 12/056,190, and U.S. Provisional Patent Application Ser. No. 60/908,742 are all incorporated herein by reference in their entireties.

US Referenced Citations (677)
Number Name Date Kind
2549836 McIntyre et al. Apr 1951 A
3490439 Rolston Jan 1970 A
3572322 Wade Mar 1971 A
3735753 Pisarski May 1973 A
3880144 Coursin et al. Apr 1975 A
3901215 John Aug 1975 A
3998213 Price Dec 1976 A
4075657 Weinblatt Feb 1978 A
4145122 Rinard et al. Mar 1979 A
4149716 Scudder Apr 1979 A
4201224 John May 1980 A
4279258 John Jul 1981 A
4411273 John Oct 1983 A
4417592 John Nov 1983 A
4537198 Corbett Aug 1985 A
4557270 John Dec 1985 A
4610259 Cohen et al. Sep 1986 A
4613951 Chu Sep 1986 A
4626904 Lurie Dec 1986 A
4632122 Johansson et al. Dec 1986 A
4683892 Johansson et al. Aug 1987 A
4686999 Snyder et al. Aug 1987 A
4695879 Weinblatt Sep 1987 A
4736751 Gevins et al. Apr 1988 A
4800888 Itil et al. Jan 1989 A
4802484 Friedman et al. Feb 1989 A
4846190 John Jul 1989 A
4859050 Borah et al. Aug 1989 A
4870579 Hey Sep 1989 A
4885687 Carey Dec 1989 A
4894777 Negishi et al. Jan 1990 A
4913160 John Apr 1990 A
4967038 Gevins et al. Oct 1990 A
4955388 Silberstein Nov 1990 A
4973149 Hutchinson Nov 1990 A
4987903 Keppel et al. Jan 1991 A
5003986 Finitzo et al. Apr 1991 A
5010891 Chamoun Apr 1991 A
5038782 Gevins et al. Aug 1991 A
5052401 Sherwin Oct 1991 A
5083571 Prichep Jan 1992 A
RE34015 Duffy Aug 1992 E
5137027 Rosenfeld Aug 1992 A
5213338 Brotz May 1993 A
5226177 Nickerson Jul 1993 A
5243517 Schmidt Sep 1993 A
5273037 Itil et al. Dec 1993 A
5291888 Tucker Mar 1994 A
5293867 Oommen Mar 1994 A
5295491 Gevins Mar 1994 A
5331544 Lu et al. Jul 1994 A
5339826 Schmidt et al. Aug 1994 A
5345281 Taboada et al. Sep 1994 A
5357957 Itil et al. Oct 1994 A
5363858 Farwell Nov 1994 A
5392788 Hudspeth Feb 1995 A
5406956 Farwell Apr 1995 A
5410609 Kado et al. Apr 1995 A
5436830 Zaltman Jul 1995 A
5447166 Gevins Sep 1995 A
5450855 Rosenfeld Sep 1995 A
5474082 Junker Dec 1995 A
5479934 Imran Jan 1996 A
5513649 Gevins et al. May 1996 A
5518007 Becker May 1996 A
5537618 Boulton et al. Jul 1996 A
5550928 Lu et al. Aug 1996 A
5617855 Waletzky et al. Apr 1997 A
5655534 Ilmoniemi Aug 1997 A
5676138 Zawilinski Oct 1997 A
5676148 Koo et al. Oct 1997 A
5687322 Deaton et al. Nov 1997 A
5720619 Fisslinger Feb 1998 A
5724987 Gevins et al. Mar 1998 A
5726701 Needham Mar 1998 A
5729205 Kwon Mar 1998 A
5736986 Sever, Jr. Apr 1998 A
5740035 Cohen et al. Apr 1998 A
5762611 Lewis et al. Jun 1998 A
5771897 Zufrin Jun 1998 A
5774591 Black et al. Jun 1998 A
5787187 Bouchard et al. Jul 1998 A
5800351 Mann Sep 1998 A
5802208 Podilchuk et al. Sep 1998 A
5802220 Black et al. Sep 1998 A
5812642 Leroy Sep 1998 A
5817029 Gevins et al. Oct 1998 A
5842199 Miller et al. Nov 1998 A
5848399 Burke Dec 1998 A
5892566 Bullwinkel Apr 1999 A
5945863 Coy Aug 1999 A
5961332 Joao Oct 1999 A
5974262 Fuller et al. Oct 1999 A
5983129 Cowan et al. Nov 1999 A
5995868 Dorfmeister et al. Nov 1999 A
6001065 DeVito Dec 1999 A
6016475 Miller et al. Jan 2000 A
6021346 Ryu et al. Feb 2000 A
6032129 Greef et al. Feb 2000 A
6052619 John Apr 2000 A
6088040 Oda et al. Jul 2000 A
6099319 Zaltman et al. Aug 2000 A
6120440 Goknar Sep 2000 A
6128521 Marro et al. Oct 2000 A
6154669 Hunter et al. Nov 2000 A
6155927 Levasseur et al. Dec 2000 A
6161030 Levendowski et al. Dec 2000 A
6170018 Voll et al. Jan 2001 B1
6171239 Humphrey Jan 2001 B1
6173260 Slaney Jan 2001 B1
6175753 Menkes et al. Jan 2001 B1
6182113 Narayanaswami Jan 2001 B1
6190314 Ark et al. Feb 2001 B1
6212502 Ball et al. Apr 2001 B1
6228038 Claessens May 2001 B1
6236885 Hunter et al. May 2001 B1
6236975 Boe et al. May 2001 B1
6254536 DeVito Jul 2001 B1
6280198 Calhoun et al. Aug 2001 B1
6286005 Cannon Sep 2001 B1
6289234 Mueller Sep 2001 B1
6292688 Patton Sep 2001 B1
6299308 Voronka et al. Oct 2001 B1
6301492 Zonenshayn Oct 2001 B1
6301493 Marro et al. Oct 2001 B1
6315569 Zaltman Nov 2001 B1
6330470 Tucker et al. Dec 2001 B1
6334778 Brown Jan 2002 B1
6358201 Childre et al. Mar 2002 B1
6370513 Kolawa et al. Apr 2002 B1
6374143 Berrang et al. Apr 2002 B1
6381481 Levendowski et al. Apr 2002 B1
6398643 Knowles et al. Jun 2002 B1
6422999 Hill Jul 2002 B1
6434419 Gevins et al. Aug 2002 B1
6435878 Reynolds et al. Aug 2002 B1
6453194 Hill Sep 2002 B1
6453241 Bassett, Jr. et al. Sep 2002 B1
6487444 Mimura Nov 2002 B2
6488617 Katz Dec 2002 B1
6510333 Licata et al. Jan 2003 B1
6510340 Jordan Jan 2003 B1
6520905 Surve et al. Feb 2003 B1
6545685 Dorbie Apr 2003 B1
6575902 Burton Jun 2003 B1
6577329 Flickner et al. Jun 2003 B1
6585521 Obrador Jul 2003 B1
6594521 Tucker Jul 2003 B2
6598006 Honda et al. Jul 2003 B1
6609024 Ryu et al. Aug 2003 B1
6648822 Hamamoto et al. Nov 2003 B2
6652283 Van Schaack et al. Nov 2003 B1
6654626 Devlin et al. Nov 2003 B2
6662052 Sarwal et al. Dec 2003 B1
6665560 Becker et al. Dec 2003 B2
6678685 McGill et al. Jan 2004 B2
6688890 von Buegner Feb 2004 B2
6708051 Durousseau Mar 2004 B1
6712468 Edwards Mar 2004 B1
6754524 Johnson, Jr. Jun 2004 B2
6757556 Gopenathan et al. Jun 2004 B2
6788882 Geer et al. Sep 2004 B1
6792304 Silberstein Sep 2004 B1
6842877 Robarts et al. Jan 2005 B2
6850252 Hoffberg Feb 2005 B1
6852875 Prakash Feb 2005 B2
6888457 Wilkinson et al. May 2005 B2
6904408 McCarthy et al. Jun 2005 B1
6950698 Sarkela et al. Sep 2005 B2
6958710 Zhang et al. Oct 2005 B2
6973342 Swanson Dec 2005 B1
6993380 Modarres Jan 2006 B1
7020508 Stivoric et al. Mar 2006 B2
7043056 Edwards et al. May 2006 B2
7047550 Yasukawa et al. May 2006 B1
7113916 Hill Sep 2006 B1
7120880 Dryer et al. Oct 2006 B1
7130673 Tolvanen-Laakso et al. Oct 2006 B2
7150715 Collura et al. Dec 2006 B2
7164967 Etienne-Cummings et al. Jan 2007 B2
7177675 Suffin et al. Feb 2007 B2
7222071 Neuhauser et al. May 2007 B2
7246081 Hill Jul 2007 B2
7249708 McConnell et al. Jul 2007 B2
7272982 Neuhauser et al. Sep 2007 B2
7286871 Cohen Oct 2007 B2
7340060 Tomkins et al. Mar 2008 B2
7359894 Liebman et al. Apr 2008 B1
7391835 Gross et al. Jun 2008 B1
7394385 Franco, Jr. et al. Jul 2008 B2
7408460 Crystal et al. Aug 2008 B2
7420464 Fitzgerald et al. Sep 2008 B2
7443292 Jensen et al. Oct 2008 B2
7460827 Schuster et al. Dec 2008 B2
7463143 Forr et al. Dec 2008 B2
7463144 Crystal et al. Dec 2008 B2
7471987 Crystal et al. Dec 2008 B2
7483835 Neuhauser et al. Jan 2009 B2
7483844 Takakura et al. Jan 2009 B2
7496400 Hoskonen et al. Feb 2009 B2
7548774 Kurtz et al. Jun 2009 B2
7551952 Gevins et al. Jun 2009 B2
7592908 Zhang et al. Sep 2009 B2
7614066 Urdang et al. Nov 2009 B2
7623823 Zito et al. Nov 2009 B2
7630757 Dorfmeister et al. Dec 2009 B2
7636456 Collins et al. Dec 2009 B2
7641341 Weinblatt Jan 2010 B2
7650793 Jensen et al. Jan 2010 B2
7658327 Tuchman et al. Feb 2010 B2
7689272 Farwell Mar 2010 B2
7697979 Martinerie et al. Apr 2010 B2
7698238 Barletta et al. Apr 2010 B2
7720351 Levitan May 2010 B2
7729755 Laken Jun 2010 B2
7765564 Deng Jul 2010 B2
7774052 Burton et al. Aug 2010 B2
7797186 Dybus Sep 2010 B2
7809420 Hannula et al. Oct 2010 B2
7840248 Fuchs et al. Nov 2010 B2
7840250 Tucker Nov 2010 B2
7844484 Arnett et al. Nov 2010 B2
7865394 Calloway et al. Jan 2011 B1
7892764 Xiong et al. Feb 2011 B2
7895075 Gettys et al. Feb 2011 B2
7895625 Bryan et al. Feb 2011 B1
7908133 Neuhauser Mar 2011 B2
7917366 Levanon et al. Mar 2011 B1
7930199 Hill Apr 2011 B1
7962315 Jensen et al. Jun 2011 B2
7988557 Soderland Aug 2011 B2
8014847 Shastri et al. Sep 2011 B2
8027518 Baker et al. Sep 2011 B2
8055722 Hille Nov 2011 B2
8065203 Chien et al. Nov 2011 B1
8069125 Jung et al. Nov 2011 B2
8073707 Teller et al. Dec 2011 B2
8082215 Jung et al. Dec 2011 B2
8086563 Jung et al. Dec 2011 B2
8098152 Zhang et al. Jan 2012 B2
8099315 Amento et al. Jan 2012 B2
8103328 Turner et al. Jan 2012 B2
8126220 Greig Feb 2012 B2
8135606 Dupree Mar 2012 B2
8151298 Begeja et al. Apr 2012 B2
8165916 Hofberg et al. Apr 2012 B2
8196168 Bryan et al. Jun 2012 B1
8200775 Moore Jun 2012 B2
8209224 Pradeep et al. Jun 2012 B2
8219438 Moon et al. Jul 2012 B1
8229469 Zhang et al. Jul 2012 B2
8235725 Hill Aug 2012 B1
8255267 Breiter Aug 2012 B2
8270814 Pradeep et al. Sep 2012 B2
8296172 Marci et al. Oct 2012 B2
8300526 Saito et al. Oct 2012 B2
8335715 Pradeep et al. Dec 2012 B2
8381244 King et al. Feb 2013 B2
8386312 Pradeep et al. Feb 2013 B2
8386313 Pradeep et al. Feb 2013 B2
8392250 Pradeep et al. Mar 2013 B2
8392251 Pradeep et al. Mar 2013 B2
8392253 Pradeep et al. Mar 2013 B2
8392254 Pradeep et al. Mar 2013 B2
8392255 Pradeep et al. Mar 2013 B2
8396744 Pradeep et al. Mar 2013 B2
8473345 Pradeep et al. Jun 2013 B2
8484081 Pradeep et al. Jul 2013 B2
8484801 Pradeep et al. Jul 2013 B2
8494610 Pradeep et al. Jul 2013 B2
8494905 Pradeep et al. Jul 2013 B2
8533042 Pradeep et al. Sep 2013 B2
8548852 Pradeep et al. Oct 2013 B2
8561095 Dimitrova et al. Oct 2013 B2
8635105 Pradeep et al. Jan 2014 B2
8655428 Pradeep et al. Feb 2014 B2
8655437 Pradeep et al. Feb 2014 B2
8709054 Lowry et al. Apr 2014 B2
8762202 Pradeep et al. Jun 2014 B2
8764652 Lee et al. Jul 2014 B2
8788372 Kettner et al. Jul 2014 B2
8793715 Weitzenfeld et al. Jul 2014 B1
9336535 Pradeep et al. May 2016 B2
9560984 Pradeep et al. Feb 2017 B2
9886981 Pradeep et al. Feb 2018 B2
10068248 Knight et al. Sep 2018 B2
10127572 Pradeep et al. Nov 2018 B2
10140628 Pradeep et al. Nov 2018 B2
10269036 Knight et al. Apr 2019 B2
10580031 Pradeep et al. Mar 2020 B2
10679241 Pradeep et al. Jun 2020 B2
10733625 Pradeep et al. Aug 2020 B2
10937051 Pradeep et al. Mar 2021 B2
20010013009 Greening et al. Aug 2001 A1
20010020236 Cannon Sep 2001 A1
20010029468 Yamaguchi et al. Oct 2001 A1
20010032140 Hoffman Oct 2001 A1
20010056225 DeVito Dec 2001 A1
20020053076 Landesmann May 2002 A1
20020055857 Mault May 2002 A1
20020056087 Berezowski et al. May 2002 A1
20020056124 Hay May 2002 A1
20020059577 Lu et al. May 2002 A1
20020065826 Bell et al. May 2002 A1
20020072952 Hamzy et al. Jun 2002 A1
20020077534 DuRousseau Jun 2002 A1
20020082902 Ando et al. Jun 2002 A1
20020103429 deCharms Aug 2002 A1
20020111796 Nemoto Aug 2002 A1
20020116042 Boling Aug 2002 A1
20020143627 Barsade et al. Oct 2002 A1
20020155878 Lert, Jr. et al. Oct 2002 A1
20020156842 Signes et al. Oct 2002 A1
20020169665 Hughes et al. Nov 2002 A1
20020178440 Agnihotri Nov 2002 A1
20020188216 Kayyali et al. Dec 2002 A1
20020188217 Farwell Dec 2002 A1
20020193670 Garfield et al. Dec 2002 A1
20030013981 Gevins et al. Jan 2003 A1
20030036955 Tanaka et al. Feb 2003 A1
20030037333 Ghashghai et al. Feb 2003 A1
20030044050 Clark et al. Mar 2003 A1
20030059750 Bindler et al. Mar 2003 A1
20030063222 Creed et al. Apr 2003 A1
20030065524 Giacchetti et al. Apr 2003 A1
20030073921 Sohmer et al. Apr 2003 A1
20030081834 Philomin et al. May 2003 A1
20030093792 Labeeb et al. May 2003 A1
20030100998 Brunner et al. May 2003 A2
20030104865 Itkis et al. Jun 2003 A1
20030118975 Stamm et al. Jun 2003 A1
20030131351 Shapira Jul 2003 A1
20030149344 Nizan Aug 2003 A1
20030165270 Endrikhovski et al. Sep 2003 A1
20030177488 Smith et al. Sep 2003 A1
20030204412 Brier Oct 2003 A1
20030208754 Sridhar et al. Nov 2003 A1
20030233278 Marshall Dec 2003 A1
20040001616 Gutta et al. Jan 2004 A1
20040005143 Tsuru et al. Jan 2004 A1
20040013398 Miura et al. Jan 2004 A1
20040015608 Ellis et al. Jan 2004 A1
20040055448 Byon Mar 2004 A1
20040068431 Smith et al. Apr 2004 A1
20040073129 Caldwell et al. Apr 2004 A1
20040088289 Xu et al. May 2004 A1
20040092809 DeCharms May 2004 A1
20040098298 Yin May 2004 A1
20040101212 Fedorovskaya et al. May 2004 A1
20040133081 Teller et al. Jul 2004 A1
20040187167 Maguire et al. Sep 2004 A1
20040193068 Burton et al. Sep 2004 A1
20040210159 Kibar Oct 2004 A1
20040219184 Brown et al. Nov 2004 A1
20040220483 Yeo et al. Nov 2004 A1
20040236623 Gopalakrishnan Nov 2004 A1
20050010475 Perkowski et al. Jan 2005 A1
20050041951 Inoue et al. Feb 2005 A1
20050043646 Viirre et al. Feb 2005 A1
20050060312 Curtiss et al. Mar 2005 A1
20050062637 El Zabadani et al. Mar 2005 A1
20050071462 Bodin et al. Mar 2005 A1
20050071865 Martins Mar 2005 A1
20050076359 Pierson et al. Apr 2005 A1
20050079474 Lowe Apr 2005 A1
20050097594 O'Donnell et al. May 2005 A1
20050107716 Eaton et al. May 2005 A1
20050108092 Campbell et al. May 2005 A1
20050113649 Bergantino May 2005 A1
20050132401 Boccon-Gibod et al. Jun 2005 A1
20050143629 Farwell Jun 2005 A1
20050149964 Thomas et al. Jul 2005 A1
20050154290 Langleben Jul 2005 A1
20050165766 Szabo Jul 2005 A1
20050177058 Sobell Aug 2005 A1
20050197590 Osorio et al. Sep 2005 A1
20050203798 Jensen et al. Sep 2005 A1
20050216071 Devlin et al. Sep 2005 A1
20050216243 Graham et al. Sep 2005 A1
20050223237 Barletta et al. Oct 2005 A1
20050227233 Buxton et al. Oct 2005 A1
20050240956 Smith et al. Oct 2005 A1
20050246002 Martinez Nov 2005 A1
20050256905 Gruhl et al. Nov 2005 A1
20050261980 Hadi Nov 2005 A1
20050267798 Panara Dec 2005 A1
20050272017 Neuhauser et al. Dec 2005 A1
20050273017 Gordon Dec 2005 A1
20050273802 Crystal et al. Dec 2005 A1
20050288954 McCarthy et al. Dec 2005 A1
20050289582 Tavares et al. Dec 2005 A1
20060003732 Neuhauser et al. Jan 2006 A1
20060009702 Iwaki et al. Jan 2006 A1
20060010470 Kurosaki et al. Jan 2006 A1
20060035707 Nguyen et al. Feb 2006 A1
20060041548 Parsons et al. Feb 2006 A1
20060042483 Work et al. Mar 2006 A1
20060053110 McDonald et al. Mar 2006 A1
20060069663 Adar et al. Mar 2006 A1
20060093998 Vertegaal May 2006 A1
20060094934 Shirai et al. May 2006 A1
20060111044 Keller May 2006 A1
20060111644 Guttag et al. May 2006 A1
20060129458 Maggio Jun 2006 A1
20060149337 John Jul 2006 A1
20060167376 Viirre et al. Jul 2006 A1
20060168613 Wood et al. Jul 2006 A1
20060168630 Davies Jul 2006 A1
20060176289 Hom Aug 2006 A1
20060189886 Jones et al. Aug 2006 A1
20060190822 Basson et al. Aug 2006 A1
20060218046 Carfi et al. Sep 2006 A1
20060256133 Rosenberg Nov 2006 A1
20060257834 Lee et al. Nov 2006 A1
20060259360 Flinn et al. Nov 2006 A1
20060259371 Perrier et al. Nov 2006 A1
20060293921 McCarthy et al. Dec 2006 A1
20070005752 Chawla et al. Jan 2007 A1
20070016096 McNabb Jan 2007 A1
20070038516 Apple et al. Feb 2007 A1
20070048707 Caamano et al. Mar 2007 A1
20070050256 Walker et al. Mar 2007 A1
20070055169 Lee et al. Mar 2007 A1
20070060830 Le et al. Mar 2007 A1
20070060831 Le et al. Mar 2007 A1
20070066874 Cook Mar 2007 A1
20070066915 Frei et al. Mar 2007 A1
20070066916 Lemos Mar 2007 A1
20070067007 Schulman et al. Mar 2007 A1
20070067305 Ives Mar 2007 A1
20070078700 Lenzmann et al. Apr 2007 A1
20070078706 Datta et al. Apr 2007 A1
20070079331 Datta et al. Apr 2007 A1
20070101360 Gutta et al. May 2007 A1
20070106170 Dunseath, Jr. et al. May 2007 A1
20070112460 Kiselik May 2007 A1
20070135727 Virtanen et al. Jun 2007 A1
20070135728 Snyder et al. Jun 2007 A1
20070136753 Bovenschulte et al. Jun 2007 A1
20070150281 Hoff Jun 2007 A1
20070150916 Begole et al. Jun 2007 A1
20070209047 Hallberg et al. Sep 2007 A1
20070214471 Rosenberg Sep 2007 A1
20070225585 Washbon et al. Sep 2007 A1
20070225674 Molnar et al. Sep 2007 A1
20070226760 Neuhauser et al. Sep 2007 A1
20070235716 Delic et al. Oct 2007 A1
20070238945 Delic et al. Oct 2007 A1
20070244977 Atkins Oct 2007 A1
20070250846 Swix et al. Oct 2007 A1
20070250901 McIntire et al. Oct 2007 A1
20070265507 de Lemos Nov 2007 A1
20070282566 Whitlow et al. Dec 2007 A1
20070294132 Zhang et al. Dec 2007 A1
20070294705 Gopalakrishnan et al. Dec 2007 A1
20070294706 Neuhauser et al. Dec 2007 A1
20080001600 deCharms Jan 2008 A1
20080004940 Rolleston Phillips Jan 2008 A1
20080010110 Neuhauser et al. Jan 2008 A1
20080024725 Todd Jan 2008 A1
20080027345 Kumada et al. Jan 2008 A1
20080040740 Plotnick et al. Feb 2008 A1
20080043013 Gruttadauria et al. Feb 2008 A1
20080059997 Plotnick et al. Mar 2008 A1
20080065468 Berg et al. Mar 2008 A1
20080065721 Cragun Mar 2008 A1
20080081961 Westbrook et al. Apr 2008 A1
20080082019 Ludving et al. Apr 2008 A1
20080086356 Glassman et al. Apr 2008 A1
20080091463 Shakamuri Apr 2008 A1
20080091512 Marci et al. Apr 2008 A1
20080097854 Young Apr 2008 A1
20080109840 Walter et al. May 2008 A1
20080125110 Ritter May 2008 A1
20080133724 Clark Jun 2008 A1
20080147448 Tunick et al. Jun 2008 A1
20080147742 Allen Jun 2008 A1
20080152300 Knee et al. Jun 2008 A1
20080162182 Cazares et al. Jul 2008 A1
20080177197 Lee et al. Jul 2008 A1
20080195471 Dube et al. Aug 2008 A1
20080204273 Crystal et al. Aug 2008 A1
20080208072 Fadem et al. Aug 2008 A1
20080214902 Lee et al. Sep 2008 A1
20080218472 Breen et al. Sep 2008 A1
20080221400 Lee et al. Sep 2008 A1
20080221472 Lee et al. Sep 2008 A1
20080221969 Lee et al. Sep 2008 A1
20080222670 Lee et al. Sep 2008 A1
20080222671 Lee et al. Sep 2008 A1
20080228077 Wilk et al. Sep 2008 A1
20080249865 Angell et al. Oct 2008 A1
20080255949 Genco et al. Oct 2008 A1
20080263458 Altberg et al. Oct 2008 A1
20080295126 Lee et al. Nov 2008 A1
20080306398 Uchiyama et al. Dec 2008 A1
20090018996 Hunt et al. Jan 2009 A1
20090024049 Pradeep et al. Jan 2009 A1
20090024448 Pradeep et al. Jan 2009 A1
20090024449 Pradeep et al. Jan 2009 A1
20090024475 Pradeep et al. Jan 2009 A1
20090024747 Moses et al. Jan 2009 A1
20090025023 Pradeep et al. Jan 2009 A1
20090025024 Beser et al. Jan 2009 A1
20090030287 Pradeep et al. Jan 2009 A1
20090030303 Pradeep et al. Jan 2009 A1
20090030717 Pradeep et al. Jan 2009 A1
20090030762 Lee et al. Jan 2009 A1
20090030780 York et al. Jan 2009 A1
20090030930 Pradeep et al. Jan 2009 A1
20090036755 Pradeep et al. Feb 2009 A1
20090036756 Pradeep et al. Feb 2009 A1
20090037575 Crystal et al. Feb 2009 A1
20090060240 Coughlan et al. Mar 2009 A1
20090062629 Pradeep et al. Mar 2009 A1
20090062679 Tan et al. Mar 2009 A1
20090062680 Sandford Mar 2009 A1
20090062681 Pradeep et al. Mar 2009 A1
20090063255 Pradeep et al. Mar 2009 A1
20090063256 Pradeep et al. Mar 2009 A1
20090069652 Lee et al. Mar 2009 A1
20090070798 Lee et al. Mar 2009 A1
20090082643 Pradeep et al. Mar 2009 A1
20090082689 Guttag et al. Mar 2009 A1
20090083129 Pradeep et al. Mar 2009 A1
20090088610 Lee et al. Apr 2009 A1
20090089830 Chandratillake et al. Apr 2009 A1
20090094286 Lee et al. Apr 2009 A1
20090094627 Lee et al. Apr 2009 A1
20090094628 Lee et al. Apr 2009 A1
20090094629 Lee et al. Apr 2009 A1
20090097689 Prest et al. Apr 2009 A1
20090098524 Walton Apr 2009 A1
20090112077 Nguyen et al. Apr 2009 A1
20090131764 Lee et al. May 2009 A1
20090132441 Muller et al. May 2009 A1
20090133047 Lee et al. May 2009 A1
20090138356 Pomplun May 2009 A1
20090150919 Lee et al. Jun 2009 A1
20090153328 Otani et al. Jun 2009 A1
20090158308 Weitzenfeld et al. Jun 2009 A1
20090163777 Jung et al. Jun 2009 A1
20090024447 Pradeep et al. Jul 2009 A1
20090195392 Zalewski Aug 2009 A1
20090214060 Chuang et al. Aug 2009 A1
20090221928 Einav et al. Sep 2009 A1
20090248484 Surendran et al. Oct 2009 A1
20090248496 Hueter et al. Oct 2009 A1
20090253996 Lee et al. Oct 2009 A1
20090259137 Delic et al. Oct 2009 A1
20090259509 Landvater Oct 2009 A1
20090271294 Hadi Oct 2009 A1
20090292587 Fitzgerald Nov 2009 A1
20090300672 Van Gulik Dec 2009 A1
20090305006 Steffen Dec 2009 A1
20090318773 Jung et al. Dec 2009 A1
20090318826 Green et al. Dec 2009 A1
20090327068 Pradeep et al. Dec 2009 A1
20090328089 Pradeep et al. Dec 2009 A1
20100004977 Marci et al. Jan 2010 A1
20100022821 Dubi et al. Jan 2010 A1
20100030578 Siddique et al. Feb 2010 A1
20100041962 Causevic et al. Feb 2010 A1
20100060300 Muller et al. Mar 2010 A1
20100094702 Silberstein Apr 2010 A1
20100125219 Harris et al. May 2010 A1
20100145176 Himes Jun 2010 A1
20100145215 Pradeep et al. Jun 2010 A1
20100145217 Otto et al. Jun 2010 A1
20100180029 Fourman Jul 2010 A1
20100183279 Pradeep et al. Jul 2010 A1
20100186031 Pradeep et al. Jul 2010 A1
20100186032 Pradeep et al. Jul 2010 A1
20100198042 Popescu et al. Aug 2010 A1
20100214318 Pradeep et al. Aug 2010 A1
20100215289 Pradeep et al. Aug 2010 A1
20100218208 Holden Aug 2010 A1
20100228604 Desai et al. Sep 2010 A1
20100249538 Pradeep et al. Sep 2010 A1
20100249636 Pradeep et al. Sep 2010 A1
20100250325 Pradeep et al. Sep 2010 A1
20100250458 Ho Sep 2010 A1
20100257052 Zito et al. Oct 2010 A1
20100268540 Arshi et al. Oct 2010 A1
20100268573 Jain et al. Oct 2010 A1
20100269127 Krug Oct 2010 A1
20100274152 McPeck et al. Oct 2010 A1
20100274153 Tucker et al. Oct 2010 A1
20100292998 Bodlaender et al. Nov 2010 A1
20100306120 Ciptawilangga Dec 2010 A1
20100317988 Terada et al. Dec 2010 A1
20100325660 Holden Dec 2010 A1
20100331661 Nakagawa Dec 2010 A1
20100332319 Etchegoyen Dec 2010 A1
20100332331 Etchegoyen Dec 2010 A1
20110004089 Chou Jan 2011 A1
20110015503 Joffe et al. Jan 2011 A1
20110040202 Luo et al. Feb 2011 A1
20110046473 Pradeep et al. Feb 2011 A1
20110046502 Pradeep et al. Feb 2011 A1
20110046503 Pradeep et al. Feb 2011 A1
20110046504 Pradeep et al. Feb 2011 A1
20110047121 Pradeep et al. Feb 2011 A1
20110059422 Masaoka Mar 2011 A1
20110085700 Lee Apr 2011 A1
20110098593 Low et al. Apr 2011 A1
20110105937 Pradeep et al. May 2011 A1
20110106621 Pradeep et al. May 2011 A1
20110106750 Pradeep et al. May 2011 A1
20110119124 Pradeep et al. May 2011 A1
20110119129 Pradeep et al. May 2011 A1
20110131274 Hille Jun 2011 A1
20110144519 Causevic Jun 2011 A1
20110153391 Tenbrock Jun 2011 A1
20110208515 Neuhauser Aug 2011 A1
20110224569 Isenhart et al. Sep 2011 A1
20110237923 Picht et al. Sep 2011 A1
20110237971 Pradeep et al. Sep 2011 A1
20110248729 Mueller et al. Oct 2011 A2
20110257502 Lee Oct 2011 A1
20110257937 Lee Oct 2011 A1
20110270620 Pradeep et al. Nov 2011 A1
20110276504 Pradeep et al. Nov 2011 A1
20110282231 Pradeep et al. Nov 2011 A1
20110282232 Pradeep et al. Nov 2011 A1
20110282749 Pradeep et al. Nov 2011 A1
20110298706 Mann Dec 2011 A1
20110319975 Ho et al. Dec 2011 A1
20120004899 Arshi Jan 2012 A1
20120022391 Leuthardt Jan 2012 A1
20120036004 Pradeep et al. Feb 2012 A1
20120036005 Pradeep et al. Feb 2012 A1
20120046993 Hill Feb 2012 A1
20120054018 Pradeep et al. Mar 2012 A1
20120072289 Pradeep et al. Mar 2012 A1
20120083668 Pradeep et al. Apr 2012 A1
20120084139 Pradeep et al. Apr 2012 A1
20120108995 Pradeep et al. May 2012 A1
20120114305 Holden May 2012 A1
20120130800 Pradeep et al. May 2012 A1
20120173701 Tenbrock Jul 2012 A1
20120203363 McKenna et al. Aug 2012 A1
20120203559 McKenna et al. Aug 2012 A1
20120239407 Lynch et al. Sep 2012 A1
20120245978 Jain et al. Sep 2012 A1
20120284112 Pradeep et al. Nov 2012 A1
20120284332 Pradeep et al. Nov 2012 A1
20120290409 Pradeep et al. Nov 2012 A1
20130024272 Pradeep et al. Jan 2013 A1
20130046577 Marci et al. Feb 2013 A1
20130124365 Pradeep May 2013 A1
20130124623 Munter May 2013 A1
20130152506 Pradeep Jun 2013 A1
20130166373 Pradeep et al. Jun 2013 A1
20130185140 Pradeep et al. Jul 2013 A1
20130185141 Pradeep et al. Jul 2013 A1
20130185142 Pradeep et al. Jul 2013 A1
20130185144 Pradeep et al. Jul 2013 A1
20130185145 Pradeep et al. Jul 2013 A1
20130304540 Pradeep et al. Nov 2013 A1
20130332259 Pradeep et al. Dec 2013 A1
20170039591 Knight et al. Feb 2017 A1
20180247332 Pradeep et al. Aug 2018 A1
20180341977 Knight et al. Nov 2018 A1
20190005532 Pradeep et al. Jan 2019 A1
20190034958 Pradeep et al. Jan 2019 A1
20190034959 Pradeep et al. Jan 2019 A1
20190139078 Pradeep et al. May 2019 A1
20190156352 Pradeep et al. May 2019 A1
20190220888 Knight et al. Jul 2019 A1
20190282153 Pradeep et al. Sep 2019 A1
20200005339 Pradeep et al. Jan 2020 A1
20200163571 Pradeep et al. May 2020 A1
20200211033 Pradeep et al. Jul 2020 A1
20200234329 Pradeep et al. Jul 2020 A1
20200258116 Pradeep et al. Aug 2020 A1
20200364741 Pradeep et al. Nov 2020 A1
Foreign Referenced Citations (36)
Number Date Country
1087618 Mar 2001 EP
1609418 Dec 2005 EP
1374658 Nov 1974 GB
2221759 Feb 1990 GB
2001147944 May 2001 JP
2005-160805 Dec 2003 JP
2005051654 Feb 2005 JP
2006006355 Jan 2006 JP
2006227994 Aug 2006 JP
2006-305334 Nov 2006 JP
2007310454 Nov 2007 JP
200422399 Jul 2006 KR
95-018565 Jul 1995 WO
1997-017774 May 1997 WO
1997-040745 Nov 1997 WO
1997-041673 Nov 1997 WO
02-100241 Dec 2002 WO
02-102238 Dec 2002 WO
2004-049225 Jun 2004 WO
2006-009771 Jan 2006 WO
2008030831 Mar 2008 WO
2008055078 May 2008 WO
2008-064431 Jun 2008 WO
2008072739 Jun 2008 WO
2008-077178 Jul 2008 WO
2008-109694 Sep 2008 WO
2008-109699 Sep 2008 WO
2008-121651 Oct 2008 WO
2008-137579 Nov 2008 WO
2008-137581 Nov 2008 WO
2008-141340 Nov 2008 WO
2008-154410 Dec 2008 WO
2009-018374 Feb 2009 WO
2009-052833 Apr 2009 WO
2011-055291 May 2011 WO
2011-056679 May 2011 WO
Non-Patent Literature Citations (602)
Entry
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Jul. 8, 2011, 16 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Jan. 7, 2011, 19 pages.
Office Action issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,221, dated Apr. 15, 2011, 24 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,863, dated Jun. 9, 2011, 12 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,863, dated Dec. 27, 2010, 15 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Apr. 21, 2011, 10 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Dec. 3, 2010, 12 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,240, dated Jun. 10, 2011, 12 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,262, dated May 26, 2011, 15 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,262, dated Dec. 9, 2010, 13 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,066, dated Jan. 21, 2011, 16 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,066, dated Oct. 28, 2010, 14 pages.
Notice of Panel Decision from Pre-Appeal Brief Review, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,066, dated May 31, 2011, 2 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Application No. 12/135,074, dated Dec. 23, 2010, 14 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated Jun. 9, 2011, 10 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated Jul. 7, 2011, 14 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated Dec. 27, 2010, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,557, dated Dec. 27, 2010, 14 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,557, dated Jun. 9, 2011, 12 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,583, dated Jun. 21, 2011, 14 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,583, dated Dec. 27, 2010, 17 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Jun. 14, 2011, 13 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Dec. 27, 2010, 17 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/200,813, dated Jul. 6, 2011, 13 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/200,813, dated Dec. 27, 2010, 14 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated Jun. 7, 2011, 10 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,069, dated Feb. 17, 2011, 32 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,069, dated Oct. 29, 2010, 21 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/357,315, dated May 4, 2011, 9 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Jun. 7, 2011, 9 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, dated Jul. 18, 2011, 9 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Jul. 12, 2011, 15 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Aug. 10, 2011, 28 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/357,322, dated Aug. 23, 2011, 12 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,069, dated Aug. 26, 2011, 33 pages.
Restriction Requirement, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,253, dated Sep. 2, 2011, 7 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated Sep. 12, 2011, 12 pages.
Restriction Requirement, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,851, dated Sep. 12, 2011, 7 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,066, dated Sep. 29, 2011, 37 pages.
Restriction Requirement, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,225, dated Oct. 3, 2011, 6 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,388, dated Oct. 12, 2011, 27 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated Oct. 13, 2011, 22 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Oct. 19, 2011, 21 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/357,315, dated Oct. 26, 2011, 41 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,240, dated Oct. 27, 2011, 39 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,221, dated Nov. 28, 2011, 44 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,660, dated Dec. 7, 2011, 8 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,863, dated Dec. 22, 2011, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,262, dated Dec. 22, 2011, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated Dec. 22, 2011, 16 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,557, dated Dec. 22, 2011, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Dec. 22, 2011, 15 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/200,813, dated Dec. 22, 2011, 18 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,583, dated Dec. 29, 2011, 18 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated Jan. 3, 2012, 10 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, dated Jan. 4, 2012, 10 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/544,921, dated Jan. 9, 2012, 13 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/357,302, dated Jan. 17, 2012, 11 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,225, dated Jan. 20, 2012, 12 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Application No. 12/135,066, dated Jan. 24, 2012, 12 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Feb. 1, 2012, 17 pages.
Restriction Requirement, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/544,958, dated Feb. 10, 2012, 6 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,069, dated Feb. 14, 2012, 36 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/357,322, dated Feb. 14, 2012, 14 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Feb. 16, 2012, 16 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Feb. 17, 2012, 22 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,253, dated Feb. 17, 2012, 20 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated Feb. 17, 2012, 15 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/868,531, dated Mar. 1, 2012, 7 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,851, dated March 14, 2012, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Mar. 29, 2012, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/846,242, dated Mar. 29, 2012, 16 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,388, dated Apr. 6, 2012, 6 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/357,315, dated Apr. 9, 2012, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/544,958, dated May 2, 2012, 15 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/357,302, dated May 7, 2012, 11 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/868,531, dated May 8, 2012, 11 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,696, dated May 15, 2012, 6 pages.
Restriction Requirement, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/545,455, dated Jun. 13, 2012, 5 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,225, dated Jun. 15, 2012, 9 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/544,934, dated Jun. 18, 2012, 11 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,066, dated Jun. 21, 2012, 10 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,660, dated Jul. 10, 2012, 14 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Jul. 30, 2012, 15 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated Aug. 3, 2012, 8 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Jun. 8, 2012, 12 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated May 23, 2012, 11 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,388, dated Aug. 28, 2012, 3 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/545,455, dated Aug. 29, 2012, 11 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/778,828, dated Aug. 30, 2012, 9 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/778,810, dated Aug. 31, 2012, 12 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Sep. 17, 2012, 11 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,262, dated Sep. 17, 2012, 11 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,253, dated Sep. 17, 2012, 17 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, dated Sep. 18, 2012, 18 pages.
Final Rejection, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Sep. 18, 2012, 17 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Sep. 19, 2012, 10 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated Sep. 19, 2012, 10 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/853,213, dated Sep. 7, 2012, 9 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,583, dated Sep. 26, 2012, 14 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Sep. 27, 2012, 14 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,557, dated Sep. 28, 2012, 12 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,863, dated Oct. 1, 2012, 12 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/444,149, dated Oct. 4, 2012, 9 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,851, dated Oct. 4, 2012, 14 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,388, dated Oct. 5, 2012, 6 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/853,197, dated Oct. 16, 2012, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/868,531, dated Oct. 22, 2012, 5 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/846,242, dated Nov. 29, 2012, 14 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/200,813, dated Oct. 30, 2012, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Nov. 2, 2012, 5 pages.
Restriction Requirement, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,225, dated Nov. 2, 2012, 5 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,066, dated Nov. 13, 2012, 9 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,863, dated Nov. 16, 2012, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Nov. 21, 2012, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/868,531, dated Nov. 23, 2012, 5 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/913,102, dated Dec. 7, 2012, 7 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/544,958, dated Dec. 10, 2012, 16 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/853,197, dated Dec. 20, 2012, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Dec. 21, 2012, 14 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Dec. 21, 2012, 10 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,262, dated Dec. 21, 2012, 19 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated Dec. 21, 2012, 12 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,557, dated Dec. 21, 2012, 14 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Dec. 21, 2012, 17 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/200,813, dated Dec. 21, 2012, 9 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/853,213, dated Dec. 21, 2012, 10 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/868,531, dated Dec. 26, 2012, 2 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,863, dated Dec. 31, 2012, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,583, dated Dec. 31, 2012, 10 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated Jan. 4, 2013, 17 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,583, dated Jan. 11, 2013, 11 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,225, dated Jan. 11, 2013, 11 pages.
Recertified IDS and Interview Summary, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/853,197, dated Jan. 16, 2013, 6 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,557, dated Jan. 29, 2013, 17 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/85,3197, dated Jan. 29, 2013, 11 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Jan. 31, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,863, dated Jan. 31, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated Jan. 31, 2013, 10 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,583, dated Feb. 1, 2013, 11 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/200,813, dated Feb. 1, 2013, 5pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Feb. 4, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,262, dated Feb. 5, 2013, 15 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/868,531, dated Feb. 5, 2013, 8 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/853,213, dated Feb. 5, 2013, 10 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,388, dated Feb. 15, 2013, 9 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Feb. 14, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/200,813, dated Sep. 20, 2012, 11 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated Apr. 16, 2013, 10 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated Apr. 22, 2013, 11 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/058264, dated Sep. 29, 2009, 1 page.
International Search Report, issued by the International Searching Authority in connection with International Application No. PCT/US08/058264, dated Aug. 1, 2008, 2 pages.
Written Opinion, issued by the International Searching Authority in connection with International Application No. PCT/US08/058264, dated Aug. 1, 2008, 5 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/062273, dated Nov. 3, 2009, 1 page.
International Search Report, issued by the International Searching Authority in connection with International Application No. PCT/US08/062273, dated Sep. 5, 2008, 2 pages.
Written Opinion, issued by the International Searching Authority in connection with International Application No. PCT/US08/062273, dated Sep. 5, 2008, 4 pages.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US08/062275, dated Sep. 22, 2008, 2 pages.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US08/062275, dated Sep. 22, 2008, 6 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/063984, dated Nov. 17, 2009, 1 page.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US08/063984, dated Sep. 29, 2008, 3 pages.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US08/063984, dated Sep. 29, 2008, 4 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/063989, dated Nov. 17, 2009, 1 page.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US08/063989, dated Jul. 17, 2008, 2 pages.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US08/063989, dated Jul. 17, 2008, 4 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/066166, dated Dec. 7, 2009, 1 page.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US08/066166, dated Aug. 25, 2008, 2 pages.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US08/066166, dated Aug. 25, 2008, 6 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/071639, dated Feb. 2, 2010, 1 page.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US08/071639, dated Oct. 22, 2008, 4 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/074467, dated Mar. 2, 2010, 1 page.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US08/074467, dated Nov. 17, 2008, 2 pages.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US08/074467, dated Nov. 17, 2008, 4 pages.
International Preliminary Report of Patentability, issued by the International Bureau in connection with International Application No. PCT/US10/021535, dated Jul. 26, 2011, 1 page.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US10/021535, dated Mar. 23, 2010, 3 pages.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US10/021535, dated Mar. 23, 2010, 4 pages.
International Preliminary Report of Patentability, issued by the International Bureau in connection with International Application No. PCT/US09/065368, dated Jun. 23, 2011, 2 pages.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US09/065368, dated Jan. 21, 2010, 3 pages.
Written Opinion, issued by the International Bureau in connection with International Application No. PCT/US09/065368, dated Jan. 21, 2010, 7 pages.
International Preliminary Report on Patentability, issued by the International Bureau of WIPO in connection with International Application No. PCT/US08/062275, dated Nov. 3, 2009, 1 page.
International Search Report, issued by the International Bureau in connection with International Application No. PCT/US08/071639, dated Oct. 22, 2008, 3 pages.
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 08744383.4-2221/2130146, dated Jul. 27, 2011, 6 pages.
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 10173095.0-2221, dated Dec. 17, 2010, 3 pages.
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 10189294.1-2221, dated Mar. 21, 2011, 7 pages.
First Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880104982.1, dated Jan. 25, 2011, 15 pages (includes English translation).
English Translation of First Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 2008801015007, dated May 25, 2011, 8 pages.
English Translation of First Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880019166.0, dated Jul. 22, 2011, 16 pages.
English Translation of Decision of Rejection, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880104982.1, dated Sep. 23, 2011, 10 pages.
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 11006934.1-2221, dated Oct. 25, 2011, 5 pages.
English Translation of First Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 20080017883.X, dated Nov. 30, 2011, 16 pages.
English Translation of Office Action, issued by the Israel Patent Office in connection with Patent Application No. 203176, dated Feb. 21, 2012, 2 pages.
English Translation of Office Action, issued by the Israel Patent Office in connection with Patent Application No. 203177, dated Mar. 1, 2012, 2 pages.
English Translation of Second Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880101500.7, dated Apr. 5, 2012, 5 pages.
English Translation of Second Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880019166.0, dated Jun. 5, 2012, 8 pages.
English Translation of Second Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880104982.1, dated Jun. 29, 2012, 5 pages.
English Translation of Second Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880017883.X, dated Aug. 10, 2012, 9 pages.
English Translation of Office Action, issued by the Israel Patent Office in connection with Patent Application No. 203176, dated Sep. 27, 2012, 1 page.
English Translation of Office Action, issued by the Israel Patent Office in connection with Patent Application No. 203177, dated Sep. 27, 2012, 1 page.
Office Action, issued by the Japanese Patent Office in connection with Patent Application No. 2010-501190, dated Oct. 2, 2012, 10 pages (includes English translation).
English Translation of Office Action, issued by the Japanese Patent Office in connection with Patent Application No. 2010-506646, dated Oct. 23, 2012, 3 pages.
English Translation of Third Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880101500.7, dated Nov. 21, 2012, 5 pages.
English Translation of Office Action, issued by the Israeli Patent Office in connection with Patent Application No. 201187, dated Nov. 27, 2012, 2 pages.
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 08796890.5-2319/2170161, dated Dec. 7, 2012, 9 pages.
Notification to Grant Patent Right for Invention, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880104982.1, dated Jan. 14, 2013, 4 pages (includes English translation).
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 08770372.4-1265/2152155, dated Feb. 6, 2013, 7 pages.
English Translation of Third Office Action, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880017883.X, dated Mar. 18, 2013, 8 pages.
English translation of Notification to Grant Patent Right for Invention, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880101500.7, dated Apr. 3, 2013, 2 pages.
Aaker et al., “Warmth in Advertising: Measurement, Impact, and Sequence Effects,” Journal of Consumer Research, vol. 12, No. 4, pp. 365-381, (Mar. 1986), 18 pages.
Akam, et al., “Oscillations and Filtering Networks Support Flexible Routing of Information,” Neuron, vol. 67, pp. 308-320, Elsevier, (Jul. 29, 2010), 13 pages.
Allen et al., “A Method for Removing Imaging Artifact from Continuous EEG Recorded during Functional MRI,” Neuroimage, vol. 12, 230-239, (Aug. 2000), 12 pages.
Ambler, “Salience and Choice: Neural Correlates of Shopping Decisions,” Psychology & Marketing, vol. 21, No. 4, p. 247-261, Wiley Periodicals, Inc., doi: 10.1002/mar20004, (Apr. 2004), 16 pages.
Ambler et al., “Ads on the Brain: A Neuro-Imaging Comparison of Cognitive and Affective Advertising Stimuli,” London Business School, Centre for Marketing Working Paper, No. 00-902, (Mar. 2000), 23 pages.
Badre, et al. “Frontal Cortex and the Discovery of Abstract Action Rules,” Neuron, vol. 66, pp. 315-326, Elsevier, (Apr. 29, 2010), 12 pages.
Bagozzi et al., “The Role of Emotions in Marketing,” Journal of the Academy of Marketing Science, vol. 27, No. 2, pp. 184-206, Academy of Marketing Science (1999), 23 pages.
Barcelo, et al., “Prefrontal modulation of visual processing in humans,” Nature Neuroscience, vol. 3, No. 4, Nature America, http//neurosci.nature.com, (Apr. 2000), 5 pages.
Barreto et al., “Physiologic Instrumentation for Real-time Monitoring of Affective State of Computer Users,” WSEAS International Conference on Instrumentation, Measurement, Control, Circuits and Systems (IMCCAS), (2004), 6 pages.
Belch et al., “Psychophysiological and cognitive Responses to Sex in Advertising,” Advances in Consumer Research, vol. 9, pp. 424-427, (1982), 6 pages.
Bimler et al., “Categorical perception of facial expressions of emotion: Evidence from multidimensional scaling,” Cognition and Emotion, vol. 15(5), pp. 633-658 (Sep. 2001), 26 pages.
Blakeslee, “If You Have a ‘Buy Button’ in Your Brain, What Pushes It?” The New York Times, www.nytimes.com, (Oct. 19, 2004), 3 pages.
Braeutigam, “Neuroeconomics-From neural systems to economic behavior,” Brain Research Bulletin, vol. 67, pp. 355-360, Elsevier, (2005), 6 pages.
Buschman, et al., “Top-Down versus Bottom-Up Control of Attention in the Prefrontal and posterior Parietal Cortices,” Science, vol. 315, www.sciencemag.org/cgi/content/full/315/5820/1860, American Association for the Advancement of Science, (2007), 4 pages.
Buschman, et al., “Serial, Covert Shifts of Attention during Visual Search Are Reflected by the Frontal Eye Fields and Correlated with Population Oscillations,” Neuron, vol. 63, pp. 386-396, Elsevier, (Aug. 13, 2009), 11 pages.
Canolty, et al., “High Gamma Power Is Phase-Locked to Theta Oscillations in Human Neocortex,” Science, vol. 313, www.sciencemag.org, (Sep. 15, 2006), 3 pages.
Cheng, et al. “Gender Differences in the Mu Rhythm of the Human Mirror-Neuron System,” PLos ONE, vol. 3, Issue 5, www.plosone.org, (May 2008), 7 pages.
Clemons, “Resonance Marketing in the Age of the Truly Informed Consumer: Creating Profits through Differentiation and Delight,” Wharton Information Strategy & Economics Blog 2, available at http://opim.wharton.upenn.edu/˜clemons/blogs/resonanceblog.pdf, (Mar. 28, 2007), 8 pages.
Clifford, “Billboards That Look Back,” The New York Times, NYTimes.com, available at http://www.nytimes.com/2008/05/31/business/media/31billboard.html, (May 31, 2008), 4 pages.
Crawford et al., “Self-generated happy and sad emotions in low and highly hypnotizable persons during waking and hypnosis: laterality and regional EEG activity differences,” International Journal of Psychophysiology, vol. 24, pp. 239-266, (Dec. 1996), 28 pages.
Davidson, et al., “The functional neuroanatomy of emotion and affective style,” TRENDS in Cognitive Sciences, vol. 3, No. 1, (Jan. 1999), 11 pages.
De Gelder et al., “Categorical Perception of Facial Expressions: Categories and their Internal Structure,” Cognition and Emotion, vol. 11(1), pp. 1-23 (1997), 23 pages.
D'Esposito, “From cognitive to neural models of working memory,” Phil. Trans. R. Soc. B, doi: 10.1098/rstb.2007.2086, (Mar. 30, 2007), 12 pages.
Desmet, “Measuring Emotions: Development and Application of an Instrument to Measure Emotional Responses to Products,” to be published in Funology: From Usability to Enjoyment, pp. 1-13, Kluwer Academic Publishers, (Blythe et al., eds., 2004), 13 pages.
Dien, et al., “Application of Repeated Measures ANOVA to High-Density ERP Datasets: A Review and Tutorial,” in Event-Related Potentials: A Methods Handbook pp. 57-82, (Todd C. Handy, ed., 2005), 14 pages.
Edgar, et al., “Digital Filters in ERP Research,” in Event-Related Potentials: A Methods Handbook pp. 85-113, (Todd C. Handy, ed., 2005), 15 pages.
EEG Protocols, “Protocols for EEG Recording,” retrieved from the Internet on Aug. 23, 2011, http://www.q-metrx.com/EEGrecordingProtocols.pdf, (Nov. 13, 2007), 3 pages.
Engel et al., “Dynamic Predictions: Oscillations and Synchrony in Top-down Processing,” Nature Reviews: Neuroscience, vol. 2, pp. 704-716, Macmillian Magazines Ltd., (Oct. 2001), 13 pages.
Filler, “MR Neurography and Diffusion Tensor Imaging: Origins, History & Clinical Impact of the first 50,000 Cases With an Assessment of Efficacy and Utility in a Prospective 5,000 Patent Study Group,” Institute for Nerve Medicine, (Nov. 7, 2008), 56 pages.
Flinker, A. et al., “Sub-centimeter language organization in the human temporal lobe,” Brain and Language, Elsevier Inc., (2010), doi.org/10.1016/j.bandl.2010.09.009, 7 pages.
Fogelson, et al., “Prefrontal cortex is critical for contextual processing: evidence from brain lesions,” Brain: A Journal of Neurology, vol. 132, pp. 3002-3010, doi:10.1093/brain/awp230, (Aug. 27, 2009), 9 pages.
Friedman, et al., “Event-Related Potential (ERP) Studies of Memory Encoding and Retrieval: A Selective Review,” Microscopy Research and Technique 51:6-22, Wiley-Liss, Inc. (2000), 23 pages.
Fries, “A mechanism for cognitive dynamics: neuronal communication through neuronal coherence,” Trends in Cognitive Sciences, vol. 9, No. 10, pp. 474-480, Elsevier B.V. www.sciencedirect.com, (Oct. 2005), 7 pages.
Fuster, “Cortex and Memory: Emergence of a New Paradigm,” Journal of Cognitive Neuroscience, vol. 21, No. 11, pp. 2047-2072, Massachusetts Institute of Technology, (Nov. 2009), 26 pages.
Gaillard, “Problems and Paradigms in ERP Research,” Biological Psychology, Elsevier Science Publisher B.V. (1988), 10 pages.
Gargiulo et al., “A Mobile EEG System With Dry Electrodes,” (Nov. 2008), 4 pages.
Gazzaley et al., “Top-down Enhancement and Suppression of Magnitude and Speed of Neural Activity,” Journal of Cognitive Neuroscience, vol. 17, No. 3, pp. 507-517, Massachusetts Institute of Technology, (2005), 11 pages.
Griss et al., “Characterization of micromachined spiked biopotential electrodes”, Biomedical Engineering, IEEE Transactions (Jun. 2002), 8 pages.
Haq, “This Is Your Brain on Advertising,” BusinessWeek, Market Research, (Oct. 8, 2007), 4 pages.
Hartikainen et al., Manuscript Draft of “Emotionally arousing stimuli compete with attention to left hemispace,” NeuroReport, (Sep. 8, 2007), 26 pages.
Hazlett, et al., “Emotional Response to Television Commercials: Facial EMG vs. Self-Report,” Journal of Advertising Research, (Apr. 1999), 17 pages.
Herrmann, et al., “Mechanisms of human attention: event-related potentials and oscillations,” Neuroscience and Biobehavioral Reviews, pp. 465-476, Elsevier Science Ltd., www.elsvevier.com/locate/neubiorev, (2001), 12 pages.
Hopf, et al., “Neural Sources of Focused Attention in Visual Search,” Cerebral Cortex, 10:1233-1241, Oxford University Press, (Dec. 2000), 9 pages.
Jung et al., “Analysis and Visualization of Single-Trial Event-Related Potentials,” Human Brain Mapping vol. 14, 166-185 (2001), 20 pages.
Kay et al., “Identifying natural images from human brain activity,” Nature, vol. 452, pp. 352-356, Nature Publishing Group, (Mar. 20, 2008), 5 pages.
Keren, et al., “Saccadic spike potentials in gamma-band EEG: Characterization, detection and suppression,” NeuroImage, http://dx.doi: 10.1016/j.neuroimage.2009.10.057, (Oct. 2009), 16 pages.
Kishiyama, et al., “Novelty Enhancements in Memory Are Dependent on Lateral Prefrontal Cortex,” The Journal of Neuroscience, pp. 8114-8118, Society for Neuroscience (Jun. 24, 2009), 5 pages.
Kishiyama, et al., “Socioeconomic Disparities Affect Prefrontal Function in Children,” Journal of Cognitive Neuroscience pp. 1106-1115, Massachusetts Institute of Technology, (2008), 10 pages.
Klimesch, “EEG alpha and theta oscillations reflect cognitive and memory performance a review and analysis,” Brain Research Reviews, vol. 29, 169-195, (1999), 27 pages.
Knight, “Contribution of human hippocampal region to novelty detection,” Nature, vol. 383, www.nature.com, (Sep. 19, 1996), 4 pages.
Knight, “Consciousness Unchained: Ethical Issues and the Vegetative and minimally Conscious State,” The American Journal of Bioethics, 8:9, 1-2, http://dx.doi.org/10.1080/15265160802414524, (Sep. 1, 2008), 3 pages.
Knight, et al., “Prefrontal cortex regulates inhibition and excitation in distributed neural networks,” Acta Psychologica vol. 101, pp. 159-178, Elsevier (1999), 20 pages.
Knight, “Decreased Response to Novel Stimuli after Prefrontal Lesions in Man,” Electroencephalography and Clinical Neurophysiology, vol. 59, pp. 9-20, Elsevier Scientific Publishers Ireland, Ltd., (1984), 12 pages.
Krakow et al., “Methodology: EEG-correlated fMRI,” Functional Imaging in the Epilepsies, (Lippincott Williams & Wilkins, 2000), 17 pages.
Krugman, “Brain Wave Measures of Media Involvement,” Journal of Advertising Research vol. 11, 3-9 (Feb. 1971), 7 pages.
Lachaux et al., “Measuring Phase Synchrony in Brain Signals,” Human Brain Mapping 8 (1999), 194-208, 15 pages.
Lee et al., “What is ‘neuromarketing’? A discussion and agenda for future research,” International Journal of Psychophysiology, vol. 63, pp. 199-204, Elsevier (2006), 6 pages.
Lekakos, “Personalized Advertising Services Through Hybrid Recommendation Methods: The Case of Digital Interactive Television,” Department of Informatics, Cyprus University, (2004), 11 pages.
Lewis et al., “Market Researchers make Increasing use of Brain Imaging,” ACNR, vol. 5, No. 3, pp. 36-37, (Jul./Aug. 2005), 2 pages.
Luck, et al., “The speed of visual attention in schizophrenia: Electrophysiological and behavioral evidence,” Schizophrenia Research, pp. 174-195, Elsevier B.V, www.sciencedirect.com, (2006), 22 pages.
Lui et al., “Marketing Strategies in Virtual Worlds,” The Data Base for Advances in Information Systems, vol. 38, No. 4, pp. 77-80, (Nov. 2007), 4 pages.
Makeig, et al., “Mining event-related brain dynamics,” TRENDS in Cognitive Sciences, vol. 8, No. 5, (May 2004), www.sciencedirect.com, 7 pages.
Makeig, et al., “Dynamic Brain Sources of Visual Evoked Responses,” Science, vol. 295, www.sciencemag.org, (Jan. 25, 2002), 5 pages.
The Mathworks, Inc., “MATLAB Data Analysis: Version 7,” p. 4-19 (2005), 3 pages.
Merriam-Webster Online Dictionary definition for “tangible,” available at http://www.merriam-webster.com/dictionary/tangible, 1 page.
Merriam Webster Online Dictionary, Definition of Virtual Reality, available at http://www.merriam-webster.com/dictionary/virtual%20reality, 2 page.
Miltner, et al., “Coherence of gamma-band EEG activity as a basis for associative learning,” Nature, vol. 397, www.nature.com, (Feb. 4, 1999), 3 pages.
Mosby's Dictionary of Medicine, Nursing, & Health Professions, 2009, Mosby, Inc., Definition of Alpha Wave, 1 page.
Mosby's Dictionary of Medicine, Nursing, & Health Professions, 2009, Mosby, Inc., Definition of Beta Wave, 1 page.
Neurofocus—Neuroscientific Analysis for Audience Engagement, accessed on Jan. 8, 2010 at http://web.archive.org/web/20080621114525/www.neurofocus.com /BrandImage.htm, (2008), 2 pages.
Newell et al., “Categorical perception of familiar objects,” Cognition, vol. 85, Issue 2, pp. 113-143 (Sep. 2002), 31 pages.
Nielsen, “Neuroinformatics in Functional Neuroimaging,” Informatics and Mathematical Modeling, Technical University of Denmark, (Aug. 30, 2002), 241 pages.
Oberman et al., “EEG evidence for mirror neuron activity during the observation of human and robot actions: Toward an analysis of the human qualities of interactive robots,” Neurocomputing 70 (2007) 2194-2203, 10 pages.
Osborne, “Embedded Watermarking for image Verification in Telemedicine,” Thesis submitted for the degree of Doctor of Philosophy, Electrical and Electronic Engineering, University of Adelaide (2005), 219 pages.
Padgett et al., “Categorical Perception in Facial Emotion Classification,” In Proceedings of the 18th Annual Conference of the Cognitive Science Society, pp. 249-253 (1996), 5 pages.
Page et al., “Cognitive Neuroscience, Marketing and Research,” Congress 2006—Foresight—The Predictive Power of Research Conference Papers, ESOMAR Publications, (Sep. 17, 2006), 25 pages.
Paller, et al., “Validating neural correlates of familiarity,” TRENDS in Cognitive Sciences, vol. 11, No. 6, www.sciencedirect.com, (May 2, 2007), 8 pages.
Paiva et al., “Phase Synchrony Among Neuronal Oscillations in the Human Cortex,” Journal of Neuroscience 25 (2005), 3962-3972, 11 pages.
Picton, et al., “Guidelines for using human event-related potentials to study cognition: Recording standards and publication criteria,” Psychophysiology, pp. 127-152, Society for Psychophysiological Research, (2000), 26 pages.
Rizzolatti et al., “The Mirror-Neuron System,” Annu. Rev. Neurosci., vol. 27, pp. 169-192, (Mar. 5, 2004), 30 pages.
Ruchkin et al., “Modality-specific processing streams in verbal working memory: evidence from spatio-temporal patterns of brain activity,” Cognitive Brain Research, vol. 6, pp. 95-113, Elsevier, (1997), 19 pages.
Rugg, et al., “Event-related potentials and recognition memory,” TRENDS in Cognitive Sciences, vol. 11, No. 6, www.sciencedirect.com, (May 3, 2007), 7 pages.
Rugg, et al., “The ERP and cognitive psychology: conceptual issues,” (Sep. 1996), 7 pages.
“User monitoring,” Sapien Systems, available at http://web.archive.org/web/20030818043339/http:/www.sapiensystems.com/eyetracking.html, (Aug. 18, 2003), 1 page.
Simon-Thomas, et al., “Behavioral and Electrophysiological Evidence of a Right Hemisphere Bias for the Influence of Negative Emotion on Higher Cognition,” Journal of Cognitive Neuroscience, pp. 518-529, Massachusetts Institute of Technology (2005), 12 pages.
Spencer, “Averaging, Detection, and Classification of Single-Trial ERPs,” in Event-Related Potentials: A Methods Handbook, pp. 209-227, (Todd C. Handy, ed., 2005), 10 pages.
Arousal in Sport, in Encyclopedia of Applied Psychology, vol. 1, p. 159, retrieved from Google Books, (Spielberger, ed., Elsevier Academic Press, 2004), 1 page.
Srinivasan, “High-Resolution EEG: Theory and Practice,” in Event-Related Potentials: A Methods Handbook, pp. 167-188, (Todd C. Handy, ed., 2005), 12 pages.
Sullivan et al., “A brain-machine interface using dry-contact, low-noise EEG sensors,” In Proceedings of the 2008 IEEE International Symposium on Circuits and Systems, (May 18, 2008), 4 pages.
Sutherland, “Neuromarketing: What's it all about?” Retrieved from Max Sutherland's Weblog on Aug. 23, 2011, http://www.sutherlandsurvey.com/Column_pages/Neuromarketing_whats_it_all_about.htm, (Mar. 2007), 5 pages.
Swick, et al., “Contributions of Prefrontal Cortex to Recognition Memory: Electrophysiological and Behavioral Evidence,” Neuropsychology, vol. 13, No. 2, pp. 155-170, American Psychological Association, Inc. (1999), 16 pages.
Taheri, et al., “A dry electrode for EEG recording,” Electroencephalography and clinical Neurophysiology, pp. 376-383, Elsevier Science Ireland Ltd. (1994), 8 pages.
Talsma, et al., “Methods for the Estimation and Removal of Artifacts and Overlap in ERP Waveforms,” in Event-Related Potentials: A Methods Handbook, pp. 115-148, (Todd C. Handy, ed., 2005), 22 pages.
Vogel, et al., “Electrophysiological Evidence for a Postperceptual Locus of Suppression During the Attentional Blink,” Journal of Experimental Psychology: Human Perception and Performance, vol. 24, No. 6, pp. 1656-1674, (1998), 19 pages.
Voytek, et al., “Prefrontal cortex and basal ganglia contributions to visual working memory,” PNAS Early Edition, www.pnas.org/cgi/doi/10.1073/pnas.10072771Q7, (2010), 6 pages.
Voytek, et al., “Hemicraniectomy: A New Model for Human Electrophysiology with High Spatio-temporal Resolution,” Journal of Cognitive Neuroscience, vol. 22, No. 11, pp. 2491-2502, Massachusetts Institute of Technology, (Nov. 2009) 12 pages.
Wang, “Neurophysiological and Computational Principles of Cortical Rhythms in Cognition,” Physiol Rev 90: pp. 1195-1268, American Physiological Society, www.prv.org, (2010), 75 pages.
“Functional magnetic resonance imaging,” retrieved online from Wikipedia, the Free Encyclopedia on Aug. 23, 2011, at http://en.wikipedia.org/w/index.php?titie=Functional magnetic resonance imaging&oldid=319601772, (Oct. 13, 2009), 8 pages.
William, “Brain Signals to Control Movement of Computer Cursor,” Blog article: Brain Signals to Control Movement of Computer Cursor, Artificial Intelligence, retrieved from the Internet on Aug. 17, 2011, http://whatisartificialintelligence.com/899/brain-signals-to-control-movement-of-computer-cursor/, (Feb. 17, 2010), 3 pages.
Woldorf, “Distortion of ERP averages due to overlap from temporally adjacent ERPs: Analysis and correction,” Psychophysiology, Society for Psychophysiological Research, Cambridge University Press (1993), 22 pages.
Woodman, et al., “Serial Deployment of Attention During Visual Search,” Journal of Experimental Psychology: Human Perception and Performance, vol. 29, No. 1, pp. 121-138, American Physiological Association (2003), 18 pages.
Yamaguchi, et al., “Rapid-Prefrontal-Hippocampal Habituation to Novel Events,” The Journal of Neuroscience, pp. 5356-5363, Society for Neuroscience, (Apr. 29, 2004), 8 pages.
Yap et al., “TIMER: Tensor Image Morphing for Elastic Registration,” NeuroImage, vol. 47, (May 3, 2009), 15 pages.
Yuval-Greenberg, et al., “Transient Induced Gamma-Bands Response in EEG as a Manifestation of Miniature Saccades,” Neuron, vol. 58, pp. 429-441, Elsevier Inc. (May 8, 2008), 13 pages.
Ziegenfuss, “Neuromarketing: Advertising Ethical & Medical Technology,” The Brownstone Journal, vol. XII, Boston University, pp. 69-73, (May 2005), 5 pages.
Zyga, “A Baseball Cap That Can Read Your Mind,” PhysOrg.com, located at www.physorg.com/newsl30152277.html, (May 16, 2008), 11 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Apr. 25, 2013, 34 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/444,149, dated May 2, 2013, 27 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated May 8, 2013, 4 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated May 8, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated May 8, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated May 8, 2013, 7 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/569,711, dated May 14, 2013, 6 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated May 17, 2013, 6 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/778,828, dated May 23, 2013, 25 pages.
Office Communication to Applicant, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,388, dated May 24, 2013, 2 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated May 28, 2013, 12 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated May 31, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,211, dated Jun. 3, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Jun. 3, 2013, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Jun. 11, 2013, 7 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/545,455, dated Jun. 11, 2013, 9 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/056,190, dated Jun. 13, 2013, 5 pages.
Office Communication to Applicant, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,388, dated Jun. 13, 2013, 2 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/135,074, dated Jun. 21, 2013, 5 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/105,774, dated Jun. 26, 2013, 10 pages.
English Translation of Office Action, issued by the Israeli Patent Office in connection with Patent Application No. 203176, dated Apr. 23, 2013, 1 page.
English Translation of Notice Prior to Allowance, issued by the Israeli Patent Office in connection with Patent Application No. 203176, dated Jun. 30, 2013, 1 page.
Merriam-Webster Online Dictionary, Definition for “Resonance,” available at http://www.merriam-webster.com/dictionary/resonance, 4 pages.
Enghoff, Sigurd, Thesis: “Moving ICA and Time-Frequency Analysis in Event-Related EEG Studies of Selective Attention,” Technical University of Denmark, (Dec. 1999), 54 pages.
Zhang, P., “Will You Use Animation on Your Web Pages?” Doing Business on the Internet: Opportunities and Pitfalls, C. Romm and F. Sudweeks (eds.), Spring-Verlag (1999), 17 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/182,874, dated Jul. 29, 2013, 6 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Sep. 12, 2013, 13 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Sep. 13, 2013, 7 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Sep. 17, 2013, 11 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/778,828, dated Oct. 8, 2013, 11 pages.
English Translation of Office Action, issued by the Japanese Patent Office in connection with Patent Application No. 2010-523112, dated Jul. 30, 2013, 2 pages.
Decision to Grant Patent, issued by the Japanese Patent Office in connection with Patent Application No. 2010-506646, dated Aug. 6, 2013, 4 pages (includes English translation).
English Translation of Decision on Rejection, issued by the Chinese Patent Office in connection with Patent Application No. 200880017883.X, dated Aug. 5, 2013, 13 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated Oct. 23, 2013, 17 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Nov. 6, 2013, 7 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/444,149, dated Nov. 19, 2013, 11 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,253, dated Dec. 3, 2013, 16 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/199,596, dated Dec. 23, 2013, 7 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/105,774, dated Jan. 16, 2014, 11 pages.
English Translation of Office Action, issued by the Japanese Patent Office in connection with Patent Application No. 2010-520159, dated Oct. 1, 2013, 2 pages.
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 08798799.6-1657/2180825, dated Nov. 4, 2013, 9 pages.
Coan et al., “Voluntary Facial Expression and Hemispheric Asymmetry Over the Frontal Cortex,” Psycophysiology (Nov. 2001), 912-924, 14 pages.
Duchowski, “A Breadth-First Survey of Eye-tracking Applications,” Beahavior Research Methods, Instruments, and Computers (Nov. 2002), 455-470, 16 pages.
Heo et al., “Wait! Why is it Not Moving? Attractive and Distractive Ocular Responses to Web Ads,” Paper presented to AEJMC, (Aug. 2001) Washington, DC, available at http://www.psu.edu/dept/medialab/researchpage/newabstracts/wait.html, 3 pages.
Rothschild et al., “Predicting Memory for Components of TV Commercials from EEG,” Journal of Consumer Research (Mar. 1990), p. 472-478, 8 pages.
Beaver, John D., et al., “Individual Differences in Reward Drive Predict Neural Responses to Images of Food”, J. of Neuroscience, (May 10, 2006), 5160-5166, 7 pages.
Tapert, Susan F., et al., “Neural Response to Alcohol Stimuli in Adolescents With Alcohol Use Disorder”, Arch Gen Psychiatry (Jul. 2003), 727-735, 9 pages.
Shandlen, Michael N. et al., “A Computational Analysis of the Relationship between Neuronal and Behavioral Responses to Visual Motion”, The Journal of Neuroscience, (Feb. 15, 1996) 1486-1510, 25 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,541, dated Jan. 30, 2014, 12 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,550, dated Jan. 31, 2014, 5 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/965,805, dated Feb. 3, 2014, 15 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/444,149, dated Feb. 3, 2014, 5 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Feb. 4, 2014, 12 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Feb. 6, 2014, 17 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,564, dated Feb. 10, 2014, 14 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated Feb. 10, 2014, 18 pages.
Mehta, A. et al., “Reconsidering Recall and Emotion in Advertising”, Journal of Advertising Research, (Mar. 2006), 49-56, 9 pages.
Cheung, Kwok-Wai, et al., “Mining Customer Product Ratings for Personalized Marketing,” Decision Support Systems 35 (2003) 231-243, 13 pages.
English Translation of Office Action, issued by the Israel Patent Office in connection with Patent Application No. 201187, dated Apr. 2, 2013, 2 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,550, dated May 27, 2014, 8 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,660, dated Jun. 2, 2014, 13 pages.
Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,253, dated Jun. 5, 2014, 25 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Jul. 1, 2014, 16 pages.
Decision to Grant Patent, issued by the Japanese Patent Office in connection with Patent Application No. 2010-523112, dated Apr. 8, 2014, 4 pages (includes English translation).
Darrow, Chester, “Psychological and psychophysiological significance of the electroencephalogram,” Psychological Review (May 1947) 157-168, 12 pages.
Stamm, John, “On the Relationship between Reaction Time to Light and Latency of Blocking the Alpha Rhythm,” Electroencephalography and Clinical Neurophysiology (Feb. 1952), 61-68, 8 pages.
Mizuki, Yashushi, et al., “Periodic Appearance of the Theta Rhythm in the Frontal Midline Area During Performance of a Mental Task,:” Electroencephalography and Clinical Neurophysiology (Aug. 1980), 345-351, 7 pages.
Decision to Grant Patent, issued by the Korean Patent Office in connection with Patent Application No. 10-2009-7022551, dated Aug. 13, 2014, 3 pages (includes English translation).
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,541, dated Jul. 23, 2014, 13 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/965,805, dated Aug. 6, 2014, 18 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,550, dated Aug. 14, 2014, 4 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,564, dated Aug. 15, 2014, 15 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated Aug. 21, 2014, 20 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Sep. 4, 2014, 16 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/105,774, dated Sep. 18, 2014, 14 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Sep. 29, 2014, 21 pages.
Ekman, P., Friesen, W., Measuring Facial Movement, Environmental Psychology and Nonverbal Behavior, 1 (1) Fall (1976), pp. 56-75, 20 pages.
Ekman, P., Friesen, W.V., Facial Action Coding System: A Technique for Measurement of Facial Movement, Consulting Psychologists Press, Palo Alto, Calif. (1978), (Book).
Ekman, P., Friesen, W., Unmasking the Face—A Guide to Recognizing Emotions from Facial Clues, Prentice-Hall, Inc., Englewood Cliffs, N.J. (1979), (Book).
Ekman, P., Friesen, W., Ancoli, S., Facial Signs of Emotional Experience, J. Personality & Social Psychology, 39(6) (Dec. 1980), pp. 1125-1134, 10 pages.
Izard, C. E., The Maximally Discriminative Facial Movement Coding System, (Rev. ed.), Instructional Resources Center, University of Delaware, Newark, Del. (1983). (Book).
Izard, C., Dougherty, L., Hembree, E., A System for Identilving Affect Expressions by Holistic Judgments (AFFEX). Instructional Resources Center, University of Delaware, Newark, Del. (1983). (Book).
Jia, X., Nixon, M.S., Extending the Feature Set for Automatic Face Recognition, International Conference on Image Processing and Its Applications (Apr. 7-9, 1992), 6 pages.
Lisetti, C., Nasoz, F., Using Noninvasive Wearable Computers to Recognize Human Emotions from Physiological Signals, EURASIP J. Applied Signal Processing, 11 (Sep. 2004), pp. 1672-1687, 16 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 14/177,698, dated Oct. 24, 2014, 13 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Dec. 22, 2014, 3 pages.
English Translation of Notification of Provisional Rejection, issued by the Korean Patent Office in connection with Patent Application No. 10-2010-7001406, dated Oct. 21, 2014, 1 page.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,550, dated Feb. 20, 2015, 12 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,660, dated Feb. 20, 2015, 52 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/965,805, dated Mar. 6, 2015, 18 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,344, dated Apr. 9, 2015, 12 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 14/177,698, dated Apr. 24, 2015, 13 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated May 5, 2015, 7 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/105,774, dated May 14, 2015, 15 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated May 14, 2015, 22 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,564, dated May 22, 2015, 6 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/249,512, dated Jun. 30, 2015, 36 pages.
Notification of Provisional Rejection, issued by the Korean Patent Office in connection with Patent Application No. 10-2010-7001406, dated Jun. 24, 2015, 9 pages (includes partial translation).
McClure, Samuel, et al., “Neural Correlates of Behavioral Preference for Culturally Familiar Drinks,” Neuron (Oct. 14, 2004), 379-387, 9 pages.
English Translation of Office Action, issued by the Israel Patent Office in connection with Patent Application No. 201187, dated Jun. 22, 2015, 4 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Jul. 30, 2015, 14 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,253, dated Aug. 4, 2015, 29 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 14/177,698, dated Aug. 19, 2015, 12 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Sep. 11, 2015, 7 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,550, dated Sep. 2, 2015, 6 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Sep. 10, 2015, 15 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated Sep. 16, 2015, 3 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/705,525, dated Sep. 30, 2015, 12 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/965,805, dated Sep. 30, 2015, 6 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,344, dated Nov. 20, 2015, 28 pages.
Translation of Reexamination Decision, issued by the Chinese Patent Office in connection with Patent Application No. 200880017883.X, dated Nov. 13, 2015, 1 page.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Dec. 17, 2015, 14 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,541, dated Dec. 18, 2015, 7 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 14/177,698, dated Jan. 14, 2016, 36 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,660, dated Jan. 22, 2016, 38 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,525, dated Feb. 3, 2016, 22 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated Feb. 23, 2016, 24 pages.
English Translation of Notification of Provisional Rejection, issued by the Korean Patent Office in connection with Patent Application No. 10-2010-7001406, dated Jan. 26, 2016, 1 page.
English Translation of Notification to Grant Patent Right for Invention, issued by the State Intellectual Property Office of P.R. China in connection with Patent Application No. 200880017883.X, dated Feb. 3, 2016, 2 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Mar. 22, 2016, 27 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Mar. 30, 2016, 23 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,525, dated Apr. 6, 2016, 3 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,564, dated Apr. 8, 2016, 7 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/965,805, dated Apr. 21, 2016, 33 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated May 12, 2016, 61 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated May 20, 2016, 69 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/945,357, dated May 20, 2016, 22 pages.
M. Corbetta et al., “Control of Goal-Directed and Stimulus-Driven Attention in the Brain,” Nature Reviews Neuroscience, vol. 3, pp. 201-215 (Mar. 2002), 15 pages.
Becker, “A Study of Web Usability for Older Adults Seeking Online Health Resources,” ACM Transactions on Computer-Human Interaction, vol. 11, No. 4, pp. 387-406 (Dec. 2004), 20 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Jun. 17, 2016, 20 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,660, dated Jul. 29, 2016, 67 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,550, dated Jul. 27, 2016, 20 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated Aug. 8, 2016, 3 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, dated Aug. 16, 2016, 5 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated Aug. 25, 2016, 61 pages.
Notification of Provisional Rejection, issued by the Korean Patent Office in connection with Patent Application No. 10-2010-7001406, dated Jul. 27, 2016, 4 pages (includes partial translation).
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/945,357, dated Nov. 1, 2016, 22 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated Nov. 7, 2016, 3 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated Nov. 14, 2016, 18 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Nov. 14, 2016, 10 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated Nov. 29, 2016, 27 pages.
First Examination Report, issued by the European Patent Office in connection with European Application No. 08796890.5, dated Sep. 29, 2016, 4 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Dec. 15, 2016, 31 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,344, dated Jan. 26, 2017, 52 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/965,805, dated Jan. 31, 2017, 25 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, dated Feb. 9, 2017, 7 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated Mar. 2, 2017, 14 pages.
English Translation of Notice Prior to Allowance, issued by the Israeli Patent Office in connection with Patent Application No. 201187, dated Feb. 14, 2017, 1 page.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/122,253, dated Mar. 31, 2017, 37 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,525, dated Apr. 27, 2017, 45 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated May 25, 2017, 9 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Jun. 5, 2017, 39 pages.
European Patent Office, “Communication Pursuant to Article 94(3) EPC,” issued in connection with European Patent Application No. 08 744 383.4, dated Apr. 19, 2017, 6 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,344, dated Jun. 29, 2017, 38 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/945,357, dated Jul. 6, 2017, 17 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Jul. 13, 2017, 12 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,525, dated Aug. 14, 2017, 38 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Aug. 18, 2017, 2017, 11 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Sep. 19, 2017, 43 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/113,870, dated Sep. 26, 2017, 51 pages.
Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC, issued by the European Patent Office in connection with European Patent Application No. 08796890.5, on Jul. 3, 2017, 3 pages.
English Translation of First Examination Report, issued by the Indian Patent Office in connection with Indian Patent Application No. 6145/CHENP/2009, dated Aug. 16, 2017, 6 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,344, dated Oct. 2, 2017, 5 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/945,357, dated Oct. 20, 2017, 16 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,525, dated Oct. 26, 2017, 4 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, dated Oct. 31, 2017, 2017, 68 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 15/299,752, dated Nov. 3, 2017, 131 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated Nov. 15, 2017, 49 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,541, dated Dec. 6, 2017, 14 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Dec. 28, 2017, 23 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Jan. 29, 2018, 11 pages.
Ganel et al., “The Relationship Between fMRI Adapation and Repetition Priming,” NeuroImage, Jul. 18, 2006, pp. 1434-1440, 9 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,511, dated Jan. 30, 2014, 67 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,511, dated Aug. 13, 2014, 8 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,511, dated May 6, 2015, 15 pages.
Examiner's Answer, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,511, dated Feb. 18, 2016, 5 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,511, dated Mar. 1, 2018, 14 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,511, dated May 29, 2014, 8 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,541, dated Feb. 12, 2015, 6 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, dated Mar. 30, 2015, 6 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated Jun. 15, 2015, 5 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, dated Sep. 23, 2015, 16 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, dated Sep. 22, 2015, 6 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, dated Nov. 27, 2015, 5 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,564, dated Feb. 2, 2018, 10 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,550, dated Mar. 27, 2018, 13 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 15/299,752, dated Apr. 17, 2017, 21 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/884,034, dated May 3, 2018, 46 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,525, dated May 18, 2018, 31 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,541, dated Jun. 27, 2017, 62 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/730,564, dated Jun. 27, 2017, 69 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Jun. 28, 2018, 22 pages.
Decision on Request for Rehearing, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,685, dated Aug. 10, 2018, 8 pages.
Extended European Search Report, issued by the European Patent Office in connection with European Application No. 0874738.9-1952, dated Sep. 25, 2015, 6 pages.
English Translation of First Examination Report, issued by the Indian Patent Office in connection with Indian Patent Application No. 4438/KOLNP/2009, dated Sep. 25, 2017, 7 pages.
Communication Under Rule 71(3) EPC, issued by the European Patent Office in connection with European Application No. 08796890.5, dated Mar. 16, 2018, 43 pages.
English Translation of First Examination Report, issued by the Indian Patent Office in connection with Indian Patent Application No. 4441/KOLNP/2009, dated May 21, 2018, 5 pages.
Knutson et al., “Neural Predictors of Purchases,” Neuron vol. 53 (Jan. 4, 2007), pp. 147-156, 10 pages.
Schaefer et al., “Neural Correlates of Culturally Familiar Brands of Car Manufacturers,” NeuroImage, vol. 31 (2006), pp. 861-865, 5 pages.
Aharon et al., “Beautiful Faces Have Variable Reward Value: fMRI and Behavorial Evidence,” Neuron, vol. 32 (2001), pp. 537-551, 15 pages.
Hall, Bruce F., “A New Model for Measuring Advertising Effectiveness,” Journal of Advertising Research, Mar.-Apr. 2002, 10 pages.
Kamba et al., “The Krakatoa Chronicle—An Interactive, Personalized, Newspaper on the Web,” available at: http://www.w3.org/Conferences/WWW4/Papers/93/ (last accessed Nov. 2, 2015), 15 pages.
Ehrenberg et al., “Understanding Brand Performance Measures: Using Dirichlet Benchmarks,” 2004, Journal of Business Research, vol. 57, pp. 1307-1325, 19 pages.
Leeflang et al., “Building Models for Marketing Decisions,” 2000, Springer Science + Business Media, pp. 192-235, 482-521, 86 pages.
Bhattacharya, “Is your brand's loyalty too much, too little, or just right?: Explaining deviations in loyalty from the Dirichlet norm,” 1997, International Journal of Research in Marketing, vol. 14, pp. 421-435, 15 pages.
McCraty et al., “Impact of a Workplace Stress Reduction Program on Blood Pressure and Emotional Health in Hypertensive Employees”, the Journal of Alternative and Complementary Medicine, vol. 9, No. 3, 2003, pp. 355-369, Mary Ann Liebert, Inc., 15 pages.
Nikolaeva et al., “The Moderating Role of Consumer and Product Characteristics on the Value of Customized On-Line Recommendations,” 2006, International Journal of Electronic Commerce, vol. 11, No. 2, pp. 101-123, 24 pages.
Ehrenberg, “New Brands and the Existing Market,” 1991, International Journal of Market Research, vol. 33, No. 4, 10 pages.
Foxall, “The Substitutability of Brands,” 1999, Managerial and Decision Economics, vol. 20, pp. 241-257, 17 pages.
Pammer et al., “Forecasting the Penetration of a New Product—A Bayesian Approach,” 2000, Journal of Business and Economic Statistics, vol. 18, No. 4, pp. 428-435, 8 pages.
Rungie et al., “Calculation of Theoretical Brand Performance Measures from the Parameters of the Dirichlet Model,” 2004, Marketing Bulletin, Massey University, 15, Technical Note 2, pp. 1-19, 20 pages.
Uncles et al., “Patterns of Buyer Behavior: Regularities, Models, and Extensions,” 1995, Marketing Science, vol. 14, No. 3, pp. G71-G78, 9 pages.
Boltz, “The cognitive processing of film and musical soundtracks,” Haverford College, Haverford, Pennsylvania, 2004, 32(7), 1194-1205, 12 pages.
Christie et al., “Autonomic specificity of discrete emotion and dimensions of affective space: a multivariate approach,” International Journal of Psychophysiology, 51 (2004) 143-153, 11 pages.
Coombes et al., “Emotion and movement: Activation of defensive circuitry alters the magnitude of a sustained muscle contraction,” University of Florida, USA, Neuroscience Letters 396 (2006) 192-196, 5 pages.
Cryer et al. “Pull the Plug on Stress,” Harvard Business Review, Jul. 2003, 8 pages.
Demaree et al., “Predicting facial valence to negative stimuli from resting RSA: Not a function of active emotion regulation,” Cognition and Emotion vol. 20, Issue 2, 2006, pp. 161-176, published on Sep. 9, 2010, http://www.tandfonline.eom/doi/abs/10.1080/02699930500260427, 6 pages. (Abstract provided.).
Elkman et al., “Autonomic Nervous System Activity Distinguishes among Emotions,” Science, New Series, vol. 221, No. 4616. (Sep. 16, 1983), pp. 1208-1210, http://links.jstor.org/sici?sici-0036-8075%2819830916%293%3A221%3A4616%3C1208%3AANSADA%3E2.0.CO%3B2-H, 5 pages.
Elton, “Measuring emotion at the symphony,” The Boston Globe, Apr. 5, 2006, http://www.psych.mcgill.ca/labs/levitin/media/measuring_emotion_boston.html, 3 pages.
Goldberg, “Getting wired could help predict emotions,” The Boston Globe, Jun. 13, 2005, http://www.boston.com/yourlife/health/mental/articles/2005/06/13/getting_wired_could_help_predict_emotions/?page=full, 4 pages.
Gomez et al., “Respiratory Responses Associated with Affective Processing of Film Stimuli,” Biological Psychology, vol. 68, Issue 3, Mar. 2005, pp. 223-235, 2 pages. (Abstract provided.).
Hall, “Is cognitive processing the right dimension,” World Advertising Research Center, Jan. 2003, 3 pages.
Hall, “On Measuring the Power of Communications,” Journal of Advertising Research, 44, pp. 1-11, doi:10.1017/S0021849904040139, (2004), 1 page. (Abstract provided.).
Hall, “Research and strategy: a fall from grace,” ADMAP, Issue 443, pp. 18-20, 2003, 1 page. (Abstract provided).
Hubert et al., “Autonomic, neuroendocrine, and subjective responses to emotion-inducing film stimuli,” Int J Psychophysiol,Aug. 1991, 2 pages. (Abstract provided.).
Levenson et al., “Emotion and Autonomic Nervous System Activity in the Minangkabau of West Sumatra,” Department of Psychology, University of California, Berkeley, Journal of Personality and Social Psychology, 1992, 2 pages. (Abstract provided.).
Marci et al., “The effect of emotional distance on psychophysiologic concordance and perceived empathy between patient and interviewer,” Applied Psychophysiology and Biofeedback, Jun. 2006, vol. 31, issue 2, 31:115-129, 8 pages. (Abstract provided.).
McCraty et al., “Analysis of twenty-four horn heart rate variability in patients with panic disorder,” Biological Psychology, vol. 56, Issue 2, Jun. 2001, pp. 131-150, 1 page. (Abstract provided.).
McCraty et al., “Electrophysiological Evidence of Intuition: Part 1. The Surprising Role of the Heart,” The Journal of Alternative and Complementary Medicine, vol. 10, No. 1, 2004, pp. 133-143, Mary Ann Liebert, Inc., 12 pages.
McCraty et al., “Electrophysiological Evidence of Intuition: Part 2. A System-Wide Process?,” The Journal of Alternative and Complementary Medicine, vol. 10, No. 2, 2004, pp. 325-336, Mary Ann Liebert, Inc., 12 pages.
McCraty et al., “The Effects of Different Types of Music on Mood, Tension, and Mental Clarity,” Original Research, Alternative Therapies, Jan. 1998, vol. 4., No. 1, pp. 75-84, 10 pages.
McCraty et al., “The Effects of Emotions on Short-Term Power Spectrum Analysis of Heart Rate Variability,” American Journal of Cardiology, vol. 76, No. 14, Nov. 15, 1995, pp. 1089-1093, 6 pages.
McCraty et al., “The Impact of a New Emotional Self-Management Program on Stress, Emotions, Heart Rate Variability, DHEA and Cortisol,” Integrative Physiological and Behavioral Science, Apr.-Jun. 1998, vol. 33, No. 2, 151-170, 20 pages.
McCraty et al., “The Impact of an Emotional Self -Management Skills Course on Psychosocial Functioning and Autonomic Recovery to Stress in Middle School Children,” Integrative Physiological and Behavioral Science, Oct.-Dec. 1999, vol. 34, No. 4, 246-268, 23 pages.
Melillo, “Inside The Consumer Mind; What Neuroscience Can Tell Us About Marketing,” Adweek, Public Citizen's Commercial Alert, Jan. 16, 2006, http://www.adweek.com/news/advertising/inside-consumer-mind-83549, 8 pages.
Miller et al., “Influence of Specific Emotional States on Autonomic Reactivity and Pulmonary Function in Asthmatic Children,” Journal of the American Academy of Child & Adolescent Psychiatry, vol. 36, Issue 5, May 1997, pp. 669-677, 3 pages. (Abstract provided).
Murphy et al., “The Heart Reinnervates After Transplantation,” Official Journal of the Society of Thoracic Surgeons and the Southern Thoracic Surgical Association, Jun. 2000, vol. 69, Issue 6, pp. 1769-1781, 13 pages.
Rosenberg, “Emotional R.O.I.,” The Hub, May/Jun. 2006,pp. 24-25, 2 pages.
Tiller et al., “Cardiac Coherence: A New, Noninvasive Measure of Autonomic Nervous System Order,” Alternative Therapies, Jan. 1996, vol. 2, No. 1, 14 pages.
Umetani et al. “Twenty-Four Hom Time Domain Heart Rate Variability and Heart Rate: Relations to Age and Gender Over Nine Decades,” J Am Coll Cardiol, Mar. 1, 1998, pp. 593-601, 9 pages.
Von Leupoldt et al., “Emotions in a Body Plethysmograph,” Journal of Psychophysiology (2004), 18, pp. 170-176, 1 page. (Abstract provided.).
Kallman, “Effect of Blank Time on Picture Recognition,” The American Journal of Psychology, vol. 97, No. 3 (Autumn, 1984), pp. 399-406, 4 pages. (Abstract provided.).
Larose, Data Mining Methods and Models, Department of Mathematical Sciences, Central Connecticut State University, www.dbeBooks.com—An Ebook Library,published by John Wiley & Sons, Inc., 2006, 340 pages. (Book).
Han et al., Data Mining: Concepts and Techniques, 2nd Edition, Elsevier, 2006, 772 pages. (Book).
Liu et al., Web Data Mining: Exploring Hyperlinks, Contents, and Usage Data, Springer Science & Business Media, 2007, 532 pages, (Book).
Berry et al., Data Mining Techniques: For Marketing, Sales, and Customer Support, Wiley Publishing Inc., Jun. 1997, 464 pages. (Book).
Horovitz, “Watching Ads Is Real Science Research Companies Monitor Physiological Reactions to Commercials to Determine Their Effectiveness,” Los Angeles Times, Sep. 1, 1991, 3 pages.
Sung et al., “Wearable feedback systems for rehabilitation,” Journal of NeuroEngineering and Rehabilitation, Jun. 29, 2005, 12 pages.
Jaffe, Casting for Big Ideas, Adweek Magazine Series, Book 8, 2003, 256 page. (Book).
Hall, “Advertising as a Factor of Production,” ADMAP, 2003, pp. 47-49, 1 page. (Abstract provided.).
Ranii, “Adding Science to Gut Check,” The News & Observer, D3 (Apr. 6, 2005), 1 page. (Abstract provided.).
Advisory action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/608,660, dated Oct. 26, 2012, 3 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/965,805, on Sep. 10, 2018, 11 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/234,372, on Sep. 19, 2018, 8 pages.
Advisory Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Oct. 1, 2018, 4 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/037,666, dated Oct. 4, 2018, 9 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 13/708,525, dated Oct. 5, 2018, 22 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/037,666, dated Dec. 6, 2018, 7 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, on Dec. 28, 2018, 8 pages.
Decision on Request for Rehearing, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,372, on Mar. 27, 2019, 7 pages.
Summons to Attend Oral Proceedings Pursuant to Rule 115(1) EPC, issued by the European Patent Office in connection with European Patent Application No. 08744383.4, on Dec. 11, 2018, 6 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/410,380, on Jul. 8, 2019, 12 pages.
Decision on Appeal, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/413,297, on Sep. 24, 2019, 15 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Application No. 15,989,987, dated Oct. 17, 2019, 8 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/183,131, dated Nov. 18, 2019, 5 pages.
Intimation of Grant and Recordal of Patent, issued by the Indian Patent Office in connection with Indian Patent Application No. 4438/KOLNP/2009, dated Jul. 3, 2019, 1 page.
Intimation of Grant and Recordal of Patent, issued by the Indian Patent Office in connection with Indian Patent Application No. 4441/KOLNP/2009, dated Sep. 3, 2019, 1 page.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Jan. 22, 2020, 12 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/183,131, dated Mar. 24, 2020, 8 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/151,044, dated Apr. 2, 2020, 5 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/151,050, dated Apr. 6, 2020, 13 pages.
Hearing Notice issued by the Indian Patent Office in connection with Indian Patent Application No. 6145/CHENP/2009, dated Mar. 12, 2020, 2 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 15/967,939, dated Oct. 4, 2019, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 15/967,939, dated Jan. 29, 2020, 8 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Jul. 24, 2020, 14 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/193,930, dated Jul. 27, 2020, 12 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/421,864, dated Aug. 13, 2020, 24 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/151,050, dated Oct. 7, 2020, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/151,044, dated Oct. 9, 2020, 8 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/790,160, dated Oct. 29, 2020, 5 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/193,930, dated Nov. 18, 2020, 8 pages.
Kim et al., “Design for an Interactive Television Advertising System,” Proceedings for the 39th Hawaii International Conference on System Sciences (2006), 9 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 12/546,586, dated Dec. 9, 2020, 8 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/151,050, dated Jan. 22, 2021, 8 pages.
Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/421,864, dated Jan. 25, 2021, 26 pages.
Notice of Allowance, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/790,160, dated Feb. 22, 2021, 9 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/692,511, dated Feb. 24, 2021, 12 pages.
“One to One Interactive and Innerscope Research Release Preliminary Biomeasures Study Results,” PR Newswire, Feb. 28, 2007, 4 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/360,282, dated Mar. 18, 2021, 7 pages.
Non-Final Office Action, issued by the United States Patent and Trademark Office in connection with U.S. Appl. No. 16/421,864, dated Apr. 22, 2021, 18 pages.
Related Publications (1)
Number Date Country
20200258116 A1 Aug 2020 US
Provisional Applications (1)
Number Date Country
60908742 Mar 2007 US
Continuations (3)
Number Date Country
Parent 15967939 May 2018 US
Child 16863671 US
Parent 13730511 Dec 2012 US
Child 15967939 US
Parent 12056190 Mar 2008 US
Child 13730511 US